+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 10819

Chapter 10819 contains a list of PDF Full Texts available from EurekaMag.

Gil, J.; Esteban, M.; Roth, D., 2000:
In vivo regulation of protein synthesis by phosphorylation of the alpha subunit of wheat eukaryotic initiation factor 2

Wright, C.E.; Bodell, P.W.; Haddad, F.; Qin, A.X.; Baldwin, K.M., 2001:
In vivo regulation of the beta-myosin heavy chain gene in hypertensive rodent heart

Giger, J.M.; Haddad, F.; Qin, A.X.; Baldwin, K.M.; Baldwin, K.M., 2000:
In vivo regulation of the beta-myosin heavy chain gene in soleus muscle of suspended and weight-bearing rats

Gil, J.; Esteban, M.; Roth, D., 2000:
In vivo regulation of the dsRNA-dependent protein kinase PKR by the cellular glycoprotein P67

Borst, D.; Wainwright, G.; Rees, H., 2002:
In vivo regulation of the mandibular organ in the edible crab, Cancer pagurus

Boujedaini, N.; Liu, J.; Thuillez, C.; Cazin, L.; Mensah Nyagan, A.G., 2001:
In vivo regulation of vasomotricity by nitric oxide and prostanoids during gestation

Brouland, J.P.; Egan, T.; Roussi, J.; Bonneau, M.; Pignaud, G.; Bal, C.; Vaiman, M.; André, P.; Hervé, P.; Mazmanian, G.M.; Drouet, L., 1999:
In vivo regulation of von willebrand factor synthesis: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs

Kushibiki, T.; Tomoshige, R.; Fukunaka, Y.; Kakemi, M.; Tabata, Y., 2003:
In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents

Larsen, D.B.erg; Joergensen, S.; Olsen, N.V.diendal; Hansen, S.H.nore; Larsen, C., 2002:
In vivo release of bupivacaine from subcutaneously administered oily solution. Comparison with in vitro release

Arias, B.; Duran, R.; Alfonso, M., 1998:
In vivo release of dopamine and its metabolites from rat striatum in response to domoic acid

Watanobe, H., 2001:
In vivo release of prolactin-releasing peptide in rat hypothalamus in association with luteinizing hormone and prolactin surges

Dovjak, N.; Blinc, A.; Keber, D., 2002:
In vivo release of tissue-type plasminogen activator antigen from the human brachial artery

Liu, S-Jung.; Wen-Neng Ueng, S.; Lin, S-Shu.; Chan, E-Cheng., 2002:
In vivo release of vancomycin from biodegradable beads

Gunsilius, E.; Tschmelitsch, Jörg.; Eberwein, M.; Schwelberger, H.; Spizzo, G.; Kähler, C.M.; Stockhammer, Günther.; Lang, A.; Petzer, A.L.; Gastl, Günther., 2002:
In vivo release of vascular endothelial growth factor from colorectal carcinomas

Feldstein, A.; Krier, J.D.; Sarafov, M.H.; Lerman, A.; Best, P.J.; Wilson, S.H.; Lerman, L.O., 1999:
In vivo renal vascular and tubular function in experimental hypercholesterolemia

Gonzalez Beltran, F.; Morales Ramirez, P., 1999:
In vivo repair during G1 of DNA lesions eliciting sister chromatid exchanges induced by methylnitrosourea or ethylnitrosourea in BrdU substituted or unsubstituted DNA in murine salivary gland cells

Tosal, L.; Comendador, M.A.; Sierra, L.M., 2001:
In vivo repair of ENU-induced oxygen alkylation damage by the nucleotide excision repair mechanism in Drosophila melanogaster

Smith, S.A.; Engelward, B.P., 2000:
In vivo repair of methylation damage in Aag 3-methyladenine DNA glycosylase null mouse cells

Tranaeus, S.; Shi, X-Qi.; Lindgren, L-Erik.; Trollsås, K.; Angmar-Månsson, B., 2002:
In vivo repeatability and reproducibility of the quantitative light-induced fluorescence method

Grzimek, N.K.A.; Podlech, J.; Steffens, H.P.ter; Holtappels, R.; Schmalz, S.; Reddehase, M.J., 1999:
In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus

Morello, C.S.; Cranmer, L.D.; Spector, D.H., 1999:
In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83)

Rietveld, L.E.G.; Caldenhoven, E.; Stunnenberg, H.G., 2002:
In vivo repression of an erythroid-specific gene by distinct corepressor complexes

Park, J.M.; Kim, H.S.k; Han, S.J.n; Hwang, M.S.n; Lee, Y.C.ul; Kim, Y.J.on, 2000:
In vivo requirement of activator-specific binding targets of mediator

Adams, M.E.; Mueller, H.A.; Froehner, S.C., 2001:
In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4

Shimizu, R.; Takahashi, S.; Ohneda, K.; Engel, J.D.; Yamamoto, M., 2001:
In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis

Ehlen, J.C.; Grossman, G.H.; Glass, J.D., 2001:
In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus

Saidi, I.S.; Biedlingmaier, J.F.; Whelan, P., 1999:
In vivo resistance to bacterial biofilm formation on tympanostomy tubes as a function of tube material

Sousa, A.R.; Lane, S.J.; Soh, C.; Lee, T.H., 1999:
In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation

Adams, K.; Rainbow, A.J.; Wilson, B.C.; Singh, G., 1999:
In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy

Imaeda, H.; Yamamoto, H.; Takaki, A.; Fujimiya, M., 2002:
In vivo response of neutrophils and epithelial cells to lipopolysaccharide injected into the monkey ileum

Korkusuz, F.; Korkusuz, P.; Eksioglu, F.; Gursel, I.; Hasirci, V., 2001:
In vivo response to biodegradable controlled antibiotic release systems

Itoiz, M.E.; Molinari, B.; Bernaola, O.; Kreimann, E.L.; Saint-Martin, G.; Schwint, A.E., 2003:
In vivo response to the different LET regions of a 55 MeV helium ion beam

Kimura, H.; Sakata, Y.; Hamada, H.; Yoshida, Y.; Sato, O.; Deguchi, J.O.; Sugawara, Y.; Makuuchi, M.; Miyata, T., 2000:
In vivo retention of endothelial cells adenovirally transduced with tissue-type plasminogen activator and seeded onto expanded polytetrafluoroethylene

Joussen, A.M.; Huang, S.; Poulaki, V.; Camphausen, K.; Beecken, W.D.; Kirchhof, B.; Adamis, A.P., 2001:
In vivo retinal gene expression in early diabetes

Suzuki, Y.; Matsuhashi, H.; Nakazawa, M., 2003 :
In vivo retinal vascular cannulation in rabbits

Moreau, K.; Torne-Celer, C.; Faure, C.; Verdier, G.; Ronfort, C., 2000:
In vivo retroviral integration: fidelity to size of the host DNA duplication might Be reduced when integration occurs near sequences homologous to LTR ends

Izembart, A.; Aguado, E.; Gauthier, O.; Aubert, D.; Moullier, P.; Ferry, N., 1999:
In vivo retrovirus-mediated gene transfer to the liver of dogs results in transient expression and induction of a cytotoxic immune response

Sigurdsson, E.M.; Permanne, B.; Soto, C.; Wisniewski, T.; Frangione, B., 2000:
In vivo reversal of amyloid-beta lesions in rat brain

Will, Y.; Kaetzel, R.S.; Brown, M.K.; Fraley, T.S.; Reed, D.J., 2002:
In vivo reversal of glutathione deficiency and susceptibility to in vivo dexamethasone-induced apoptosis by N-acetylcysteine and L-2-oxothiazolidine-4-carboxylic acid, but not ascorbic acid, in thymocytes from gamma-glutamyltranspeptidase-deficient knockout mice

Hayashi, M.; Macgregor, J., T.; Gatehouse, D., G.; Adler, I.-Dore; Blakey, D., H.; Dertinger, S., D.; Krishna, G.; Morita, T.; Russo, A.; Sutou, S., 2000:
In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring

Krishna, G.; Hayashi, M., 2000:
In vivo rodent micronucleus assay: Protocol, conduct and data interpretation

Watson, H.A.; Cope, M.J.; Groen, A.C.; Drubin, D.G.; Wendland, B., 2001:
In vivo role for actin-regulating kinases in endocytosis and yeast epsin phosphorylation

Uchida, S., 2000:
In vivo role of CLC chloride channels in the kidney

Suzue, K.; Asai, T.; Takeuchi, T.; Koyasu, S., 2003:
In vivo role of IFN-gamma produced by antigen-presenting cells in early host defense against intracellular pathogens

Fukuda, M.N.; Akama, T.O., 2002:
In vivo role of alpha-mannosidase IIx: ineffective spermatogenesis resulting from targeted disruption of the Man2a2 in the mouse

Tomioka, M.; Shirotani, K.; Iwata, N.; Lee, H.J.n; Yang, F.; Cole, G.M.; Seyama, Y.; Saido, T.C., 2002:
In vivo role of caspases in excitotoxic neuronal death: Generation and analysis of transgenic mice expressing baculoviral caspase inhibitor, p35, in postnatal neurons

Lubinski, J.; Wang, L.; Mastellos, D.; Sahu, A.; Lambris, J.D.; Friedman, H.M., 1999:
In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC

Choudhury, B.K.; Wild, J.S.; Alam, R.; Klinman, D.M.; Boldogh, I.; Dharajiya, N.; Mileski, W.J.; Sur, S., 2002:
In vivo role of p38 mitogen-activated protein kinase in mediating the anti-inflammatory effects of CpG oligodeoxynucleotide in murine asthma

Collins, B.J.; Deak, M.; Arthur, J.Simon.C.; Armit, L.J.; Alessi, D.R., 2003:
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation

Karim, M.A., 1998:
In vivo role of the extracellular matrix during vascular repair

Luikart, B.W.; Nef, S.; Shipman, T.; Parada, L.F., 2003:
In vivo role of truncated TrkB receptors during sensory ganglion neurogenesis

Sugawara, N.; Wang, X.; Haber, J.E., 2003:
In vivo roles of Rad52, Rad54, and Rad55 proteins in Rad51-mediated recombination

Saiki, T.; Ezaki, T.; Ogawa, M.; Maeda, K.; Yagita, H.; Matsuno, K., 2001:
In vivo roles of donor and host dendritic cells in allogeneic immune response: cluster formation with host proliferating T cells

Yang, A.H.; Ishii, I.; Chun, J., 2002:
In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice

Cooper, R.N.; Tajbakhsh, S.; Mouly, V.; Cossu, G.; Buckingham, M.; Butler-Browne, G.S., 1999:
In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle

Andersen, M.; Bjerre, P.; Schroder, H.D.; Edal, A.; Hoilund Carlsen, P.F.; Pedersen, P.H.ltoft; Hagen, C., 2001:
In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas

Zielske, S.P.; Reese, J.S.; Lingas, K.T.; Donze, J.R.; Gerson, S.L., 2003:
In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning

Nakano, M.; Yasuda, M.; Yokoi, S.; Takahashi, Y.; Ishihara, S.; Deguchi, T., 2001:
In vivo selection of Pseudomonas aeruginosa with decreased susceptibilities to fluoroquinolones during fluoroquinolone treatment of urinary tract infection

Saito, M.; Taylor, G.P.; Saito, A.; Furukawa, Y.; Usuku, K.; Weber, J.N.; Osame, M.; Bangham, C.R., 2001:
In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes

Puglielli, M.T.; Zajac, A.J.; van der Most, R.G.; Dzuris, J.L.; Sette, A.; Altman, J.D.; Ahmed, R., 2001:
In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb

L.T.omas, I.; Couetdic, G.; Clermont, O.; Brahimi, N.; Plésiat, P.; Bingen, E., 2001:
In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy

Guo, F.; Cech, T.R., 2002:
In vivo selection of better self-splicing introns in Escherichia coli: the role of the P1 extension helix of the Tetrahymena intron

Moine, H.; Ehresmann, B.; Ehresmann, C., 2002:
In vivo selection of functional variations in essential sites of ribosomal RNA

Geslain, R.; Martin, F.; Delagoutte, B.; Cavarelli, J.; Gangloff, J.; Eriani, G., 2000:
In vivo selection of lethal mutations reveals two functional domains in arginyl-tRNA synthetase

Leotard, S.; Poirel, L.; Leblanc, P.E.; Nordmann, P., 2002:
In vivo selection of oxacillinase-mediated ceftazidime resistance in Pseudomonas aeruginosa

Pacini, L.; Vitelli, A.; Filocamo, G.; Bartholomew, L.; Brunetti, M.; Tramontano, A.; Steinkühler, C.; Migliaccio, G., 2000:
In vivo selection of protease cleavage sites by using chimeric Sindbis virus libraries

Johns, M.; George, A.J.T.; Ritter, M.A., 2000:
In vivo selection of sFv from phage display libraries

Portner Taliana, A.; Russell, M.; Froning, K.J.; Budworth, P.R.; Comiskey, J.D.; Hoeffler, J.P., 2000:
In vivo selection of single-chain antibodies using a yeast two-hybrid system

Zimmerman, J.M.; Maher, L.James., 2002:
In vivo selection of spectinomycin-binding RNAs

Battaile, K.P.; Bateman, R.L.; Mortimer, D.; Mulcahy, J.; Rathbun, R.K.; Bagby, G.; Fleming, W.H.; Grompe, M., 1999:
In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia

Tralhão, J.Guilherme.; Schaefer, L.; Micegova, M.; Evaristo, C.; Schönherr, E.; Kayal, S.; Veiga-Fernandes, H.; Danel, C.; Iozzo, R.V.; Kresse, H.; Lemarchand, P., 2003:
In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer

Sun, Y.; Moeller, P.; Berking, C.; Schluepen, E.M.; Volkenandt, M.; Schadendorf, D., 1999:
In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells

Hertveldt, K.; Robben, J.; Volckaert, G., 2002:
In vivo selectively infective phage as a tool to detect protein interactions: evaluation of a novel vector system with yeast Ste7p-Fus3p interacting proteins

Khan, A.A.; Brahim, J.S.; Rowan, J.S.; Dionne, R.A., 2002:
In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model

Laudanno, O.M.; Cesolari, J.A.; Esnarriaga, J.; Flaherty, P.; Vada, J.; Guastalli, G.; San Miguel, P.; Bedini, O.A., 1998:
In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats

Laudanno, O.M.; Cesolari, J.A.; Esnarriaga, J.; San Miguel, P.; Bedini, O.A., 2000:
In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats

Russell-Aulet, M.; Jaffe, C.A.; Demott-Friberg, R.; Barkan, A.L., 1999:
In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging

Ndyomugyenyi, R.; Magnussen, P., 2000:
In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine among schoolchildren in rural Uganda: a comparison between 1995 and 1998

Wu, P.C.; Alexander, H.R.; Huang, J.; Hwu, P.; Gnant, M.; Berger, A.C.; Turner, E.; Wilson, O.; Libutti, S.K., 1999:
In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII)

Cohen-Boulakia, F.; Valensi, P.E.; Boulahdour, H.; Lestrade, R.; Dufour-Lamartinie, J.F.; Hort-Legrand, C.; Behar, A., 2000:
In vivo sequential study of skeletal muscle capillary permeability in diabetic rats: effect of anthocyanosides

Moresco, F.M.; Dieci, M.; Vita, A.; Messa, C.; Gobbo, C.; Galli, L.; Rizzo, G.; Panzacchi, A.; D.P.ri, L.; Invernizzi, G.; Fazio, F., 2002:
In vivo serotonin 5HT2A receptor binding and personality traits in healthy subjects: A positron emission tomography study

McLean, M.A.; Woermann, F.G.; Simister, R.J.; Barker, G.J.; Duncan, J.S., 2001:
In vivo short echo time 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes

Ueda, H.; Inoue, M., 2000:
In vivo signal transduction of nociceptive response by kyotorphin (tyrosine-arginine) through Galpha(i)- and inositol trisphosphate-mediated Ca(2+) influx

Becker, M.D.; Kruse, F.E.; Azzam, L.; Nobiling, R.; Reichling, J.; Völcker, H.E., 1999:
In vivo significance of ICAM-1--dependent leukocyte adhesion in early corneal angiogenesis

Bugnon, D.; Potel, G.; Caillon, J.; Baron, D.; Drugeon, H.B.; Feigel, P.; Kergueris, M.F., 1998:
In vivo simulation of human pharmacokinetics in the rabbit

Sauvinet, Vérie.; Parrot, S.; Benturquia, N.; Bravo-Moratón, E.; Renaud, B.; Denoroy, L., 2003:
In vivo simultaneous monitoring of gamma-aminobutyric acid, glutamate, and L-aspartate using brain microdialysis and capillary electrophoresis with laser-induced fluorescence detection: Analytical developments and in vitro/in vivo validations

Binaschi, M.; Farinosi, R.; Borgnetto, M.E.; Capranico, G., 2000:
In vivo site specificity and human isoenzyme selectivity of two topoisomerase II-poisoning anthracyclines

Alattar, H.A.; Hassan, B.M.; Faris, F.A., 2001:
In vivo skin characterisation using light reflectance

Wester, R.C.; Hui, X.; Landry, T.; Maibach, H.I., 1999:
In vivo skin decontamination of methylene bisphenyl isocyanate (MDI): soap and water ineffective compared to polypropylene glycol, polyglycol-based cleanser, and corn oil

Simonsen, L.; Petersen, M.B.; Groth, L., 2002:
In vivo skin penetration of salicylic compounds in hairless rats

Kyoizumi, S.; Kusunoki, Y.; Seyama, T.; Hatamochi, A.; Goto, M., 1998:
In vivo somatic mutations in Werner's syndrome

He, Y.; Xing, D.; Tan, S.; Tang, Y.; Ueda, K.I.hi, 2002:
In vivo sonoluminescence imaging with the assistance of FCLA

Uchida, S.; Yamada, S.; Deguchi, Y.; Yamamoto, M.; Kimura, R., 2000:
In vivo specific binding characteristics and pharmacokinetics of a 1,4-dihydropyridine calcium channel antagonist in the senescent mouse brain

Grabenhorst, E.; Nimtz, M.; Costa, J.; Conradt, H.S., 1998:
In vivo specificity of human alpha1,3/4-fucosyltransferases III-VII in the biosynthesis of LewisX and Sialyl LewisX motifs on complex-type N-glycans. Coexpression studies from bhk-21 cells together with human beta-trace protein

Davis, M.D.ff; Schmidt, J.J., 2000:
In vivo spectrometric calcium flux recordings of intrinsic caudate-putamen cells and transplanted IMR-32 neuroblastoma cells using miniature fiber optrodes in anesthetized and awake rats and monkeys

Gonzalez Mora, J.L.; Martin, F.A.; Rojas Diaz, D.; Hernandez, S.; Ramos Perez, I.; Rodriguez, V.D.; Castellano, M.A., 2002:
In vivo spectroscopy: A novel approach for simultaneously estimating nitric oxide and hemodynamic parameters in the rat brain

Kinne, R.W.; Schemer, K.; Behr, T.; Sharkey, R.M.; Palombokinne, E.; Emmrich, F.; Goldenberg, D.M.; Wolf, F.; Becker, W., 1999:
In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments

Campbell, J.D.rren; Stinson, M.J.; Simons, F.E.telle R.; Rector, E.S.; Hayglass, K.T., 2001:
In vivo stability of human chemokine and chemokine receptor expression

Tanaka, N.; Hora, K.; Makishima, H.; Kamijo, Y.; Kiyosawa, K.; Gonzalez, F.J.; Aoyama, T., 2003:
In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha

de Meer, K.; van den Akker, J.T.; Smulders, Y.; Stam, F.; Stehouwer, C.D.A.; Finglas, P., 2002:
In vivo stable isotope measurements of methyl metabolism: applications in pathophysiology and interventions

Hsu, L.J.; Jan, M.S.; Lin, Y.S., 2000:
In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro

Stohl, W.; Xu, D.; Zang, S.; Kim, K.S.; Li, L.; Hanson, J.A.; Stohlman, S.A.; David, C.S.; Jacob, C.O., 2001:
In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II

Dichtl, W.; Ares, M.P.S.; Stollenwerk, M.; Giachelli, C.M.; Scatena, M.; Hamsten, A.; Eriksson, P.; Nilsson, J., 2000:
In vivo stimulation by vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element

Wang, M.-Mei; Reynaud, D.; Pace-Asciak, C., R., 1999:
In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: Formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability

Garcia Martinez, J.A.; Cancelas, J.; Villaneuva Penacarrillo, M.L.; Valverde, I.; Malaisse, W.J., 1999:
In vivo stimulation of insulin release by 2-deoxy-D-glucose tetraacetate

Kondo, A.; Togari, A., 2003:
In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria

Takeda, A.; Ishiwatari, S.; Okada, S., 1998:
In vivo stimulation-induced release of manganese in rat amygdala

Tanaka-Douzono, M.; Suzu, S.; Yamada, M.; Misawa, E.; Wakimoto, N.; Shimamura, S.; Hatake, K.; Motoyoshi, K., 1999:
In vivo stimulatory effect of macrophage colony-stimulating factor on the number of stroma-initiating cells

Corning; Biewener, 1998:
In vivo strains in pigeon flight feather shafts: implications for structural design

Körner, K.; Müller, R., 2000:
In vivo structure of the cell cycle-regulated human cdc25C promoter

Tommasi, S.; Pfeifer, G.P., 1999:
In vivo structure of two divergent promoters at the human PCNA locus. Synthesis of antisense RNA and S phase-dependent binding of E2F complexes in intron 1

Hong, K.; Mano, I.; Driscoll, M., 2000:
In vivo structure-function analyses of Caenorhabditis elegans MEC-4, a candidate mechanosensory ion channel subunit

Chen, X.; Fischer, J.A., 2000:
In vivo Structure/Function analysis of the Drosophila fat facets deubiquitinating enzyme gene

Grach, C.; Wang, Y.; Barda, Y.; Gilon, C.; Pener, M.P., 2003:
In vivo structureactivity studies on the dark-color-inducing neurohormone of locusts

Shashi, A., 2003:
In vivo studies concerning toxic effects of sodium fluoride on hepatic function in rabbits

Song, K.; Cowan, K.H.; Sinha, B.K., 1999:
In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts

Borrás, E.; Zaragozá, R.; Morante, Mía.; García, C.; Gimeno, A.; López-Rodas, G.; Barber, T.; Miralles, V.J.; Viña, J.R.; Torres, L., 2003:
In vivo studies of altered expression patterns of p53 and proliferative control genes in chronic vitamin A deficiency and hypervitaminosis

McClarrinon, M.; Gilkey, L.; Watral, V.; Fox, B.; Bullock, C.; Fradkin, L.; Liggitt, D.; Roche, L.; Bussey, L.B.; Fox, E.; Gorman, C., 1999:
In vivo studies of gene expression via transient transgenesis using lipid-DNA delivery

Her, G.-Mour; Chiang, C.-Chang; Chen, W.-Ya; Wu, J.-Leih, 2003:
In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio)

Kjaer, M.; Langberg, H.; Skovgaard, D.; Olesen, J.; Bulow, J.; Krogsgaard, M.; Boushel, R., 2000:
In vivo studies of peritendinous tissue in exercise

Cui, X.; Wiler, J.; Dzaman, M.; Altschuler, R.A.; Martin, D.C., 2003:
In vivo studies of polypyrrole/peptide coated neural probes

Salaj-Smic, E.; Dermić, D.; Brcić-Kostić, K.; Cajo, G.C.; Trgovcević, E., 2000:
In vivo studies of the Escherichia coli RecB polypeptide lacking its nuclease center

Chen, N.Y.; Holle, L.; Li, W.; Peirce, S.K.; Beck, M.T.; Chen, W.Y., 2002:
In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R

Tsang, S.H.; Yamashita, C.K.; Doi, K.; Salchow, D.J.; Bouvier, N.; Mendelsohn, M.; Gouras, P.; Farber, D.B.; Goff, S.P., 2001:
In vivo studies of the gamma subunit of retinal cGMP-phosphodiesterase with a substitution of tyrosine-84

Vallon, V., 2003:
In vivo studies of the genetically modified mouse kidney

Phillis, J.W.; O'regan, M.H., 2003:
In vivo studies of the release of adenine 5'-nucleotides, adenosine, and its metabolites from the rat brain

Mathieu, M.; Fillinger, S.; Felenbok, B., 2000:
In vivo studies of upstream regulatory cis-acting elements of the alcR gene encoding the transactivator of the ethanol regulon in Aspergillus nidulans

Van Reeth, K.; Van Gucht, S.; Pensaert, M., 2002:
In vivo studies on cytokine involvement during acute viral respiratory disease of swine: Troublesome but rewarding

Attrey, D.P.; Kumar, A.; Apte, C.V., 2003:
In vivo studies on garlic and ACE-inhibitors in prevention of hypoxic pulmonary hypertension in cattle in high altitude areas of Ladakh

Rafael, E.; Wernerson, A.; Arner, P.; Tibell, A., 1999:
In vivo studies on insulin permeability of an immunoisolation device intended for islet transplantation using the microdialysis technique

Pérez, M.Teresa.; García-Pérez, A.Isabel.; Pinilla, M.; Sancho, P., 2002:
In vivo studies on mouse erythrocytes linked to transferrin

Ozsoy, Y.; Tunçel, T.; Can, A.; Akev, N.; Birteksöz, S.; Gerçeker, A., 2000:
In vivo studies on nasal preparations of ciprofloxacin hydrochloride

Pryme, I.F.; Lembcke, R., 2003:
In vivo studies on possible health consequences of genetically modified food and feed--with particular regard to ingredients consisting of genetically modified plant materials

Kavitha, A.V.; Jagadeesan, G., 2003:
In vivo studies on the role of Tribulus terrestris extract on mercury intoxicated mice, Mus musculus-large intestine: A histological survey

Huong, T.M.; Harashima, H.; Kiwada, H., 1999:
In vivo studies on the role of complement in the clearance of liposomes in rats and guinea pigs

Papadopoulos, V.; Widmaier, E.P.; Amri, H.; Zilz, A.; Li, H.; Culty, M.; Castello, R.; Philip, G.H.; Sridaran, R.; Drieu, K., 1998:
In vivo studies on the role of the peripheral benzodiazepine receptor (PBR) in steroidogenesis

Irlbacher, K.; Brandt, S.A.; Meyer, B-Ulrich., 2002:
In vivo study indicating loss of intracortical inhibition in tumor-associated epilepsy

Diep, Q.N.; Li, J.S.; Schiffrin, E.L., 1999:
In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels

Kodjikian, L.; Burillon, C.; Chanloy, Cécile.; Bostvironnois, Vérie.; Pellon, Gérard.; Mari, E.; Freney, J.; Roger, T., 2002:
In vivo study of bacterial adhesion to five types of intraocular lenses

Ueng, S.W.N.; Yuan, L-Jen.; Lee, N.; Lin, S-Shu.; Liu, S-Jung.; Chan, E-cheng.; Weng, J-Hsun., 2002:
In vivo study of hot compressing molded 50:50 poly (DL-lactide-co-glycolide) antibiotic beads in rabbits

Hu, X.H.; Wooden, W.A.; Vore, S.J.; Cariveau, M.J.; Fang, Q.; Kalmus, G.W., 2002:
In vivo study of intradermal focusing for tattoo removal

Callot, V.; Bennett, E.; Decking, U.K.M.; Balaban, R.S.; Wen, H., 2003:
In vivo study of microcirculation in canine myocardium using the IVIM method

Custodio, M., R.; Hajdu, E.; Muricy, G., 2002:
In vivo study of microsclere formation in sponges of the genus Mycale (Demospongiae, Poecilosclerida)

el Marbouh, L.; Arellano, C.; Philibert, C.; Evrard, P.; Poëy, J.; Houin, G., 2001:
In vivo study of percutaneous absorption of 4-chloroaniline using microdialysis in the rat

Jamal, M.; Ameno, K.; Ameno, S.; Okada, N.; Ijiri, I., 2003:
In vivo study of salsolinol produced by a high concentration of acetaldehyde in the striatum and nucleus accumbens of free-moving rats

Dobrev, Hristo Petrov, 1999:
In vivo study of skin mechanical properties in patients with systemic sclerosis

Lindekens, H.; Smolders, I.; Khan, G.M.; Bialer, M.; Ebinger, G.; Michotte, Y., 2000:
In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy

Tomioka, J.; Mori, T.; Yamazaki, K.; Akimoto, T.; Koyanagi, H., 2000:
In vivo study of the performance of a mechanical seal involving a recirculating cooling water system used in a centrifugal blood pump

Darbin, O.; Lonjon, M.; Quentien, M.H.; Michiels, J.F.; Grellier, P.; Negrin, J.; Rostain, J.C.; Risso, J.J., 2000:
In vivo study of tumor metabolism: An application of new multi-probe microdialysis system in the striatum of freely moving rats grafted with C6 cells

Vivekanandhan, A.; Das, S., 2001:
In vivo study on dual-signal hypothesis and its correlation to immune response using mycobacterial antigen

El-Kholy, S., M.; Hussein, N., G.A.; Mahmoud, M., M.; Abdel-Tawab, S., M., 2002:
In vivo study on the effects of exposure to laser beam on antioxidant enzymes in liver and spleen of mice

Abd-El-Tawab, S.-Mohamed; Mahmoud, M.-Moustafa; Ali-Hussein, N.-Gaber, 2002:
In vivo study on the protective effect of melatonin administration on ethanol-induced gastroduodenal damage in rats

Lambert, A.; Sadir, R.; Brisson, C.; Morel, G., 2000:
In vivo subcellular target compartments of interferon-gamma and interferon-gamma receptor (alpha- and beta-chains) in mouse liver

Zien, C.A.; Wang, C.; Wang, X.; Welti, R., 2001:
In vivo substrates and the contribution of the common phospholipase D, PLDalpha, to wound-induced metabolism of lipids in Arabidopsis

Uchida, A.; O'keefe, D.S.; Bacich, D.J.; Molloy, P.L.; Heston, W.D.W., 2001:
In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: A potential alternative approach to androgen deprivation therapy

Fennell, D.A.; Corbo, M.V.; Dean, N.M.; Monia, B.P.; Cotter, F.E., 2001:
In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model

Shirakawa, T.; Ko, S.C.u; Gardner, T.A.; Cheon, J.; Miyamoto, T.; Gotoh, A.; Chung, L.W.K.; Kao, C., 1998 :
In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promote-based toxic gene therapy

Thomason, J.J.; Grovum, L.E.; Deswysen, A.G.; Bignell, W.W., 2001:
In vivo surface strain and stereology of the frontal and maxillary bones of sheep: Implications for the structural design of the mammalian skull

Prlic, M.; Blazar, B.R.; Farrar, M.A.; Jameson, S.C., 2003:
In vivo survival and homeostatic proliferation of natural killer cells

Perez, M.T.resa; Pinilla, M.; Sancho, P., 1999:
In vivo survival of selected murine carrier red blood cells after separation by density gradients or aqueous polymer two-phase systems

Ufret-Vincenty, R.L.; Quigley, L.; Tresser, N.; Pak, S.H.; Gado, A.; Hausmann, S.; Wucherpfennig, K.W.; Brocke, S., 1998:
In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis

Forgie, A.; Kuehnel, F.; Wyatt, S.; Davies, A.M., 2000:
In vivo survival requirement of a subset of nodose ganglion neurons for nerve growth factor

Dhople, A., M.; Namba, K., 2003:
In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues

Giacchino, J.; Criado, J.R.; Games, D.; Henriksen, S., 2000:
In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice

Schiffelers, R.M.; Storm, G.; ten Kate, M.T.; Stearne-Cullen, L.E.; den Hollander, J.G.; Verbrugh, H.A.; Bakker-Woudenberg, I.A., 2001:
In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime

Chen, S.; Halkier, B.A.n, 2000 :
In vivo synthesis and purification of radioactive p-hydroxybenzylglucosinolate in Sinapis alba L

Maras, M.; Bruyn, A.D.; Vervecken, W.; Uusitalo, J.; Penttila, M.; Busson, R.; Herdewijn, P.; Contreras, R., 1999:
In vivo synthesis of complex N-glycans by expression of human N-acetylglucosaminyltransferase I in the filamentous fungus Trichoderma reesei

Maruyama, K., 2000:
In vivo targeting by liposomes

Abounader, R.; Lal, B.; Luddy, C.; Koe, G.; Davidson, B.; Rosen, E.M.; Laterra, J., 2001:
In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis

De Palma, M.; Venneri, M.Anna.; Naldini, L., 2003:
In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors

You, H.J.; Viswanathan, A.; Doetsch, P.W., 2000:
In vivo technique for determining transcriptional mutagenesis

Novotny, J.E.; Woolley, C.T.; Nichols, C.E.; Beynnon, B.D., 2000:
In vivo technique to quantify the internal-external rotation kinematics of the human glenohumeral joint

Verheye, S.; D.M.yer, G.R.Y.; Van Langenhove, G.; Knaapen, M.W.M.; Kockx, M.M., 2002:
In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition

Bert, L.; Parrot, S.; Robert, F.; Desvignes, C.; Denoroy, L.; Suaud Chagny, M.F.; Renaud, B., 2002:
In vivo temporal sequence of rat striatal glutamate, aspartate and dopamine efflux during apomorphine, nomifensine, NMDA and PDC in situ administration

Malaviya, P.; Butler, D.L.; Korvick, D.L.; Proch, F.S., 1998:
In vivo tendon forces correlate with activity level and remain bounded: Evidence in a rabbit flexor tendon model

Diel, P.; Schmidt, S.; Vollmer, G., 2002:
In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens

Niedhart, C.; Maus, U.; Redmann, E.; Siebert, C.H., 2001:
In vivo testing of a new in situ setting beta-tricalcium phosphate cement for osseous reconstruction

Gerencser, A.; Hiripi, L.; Makovics, F.; Toth, S.; Szabo, G.; Bosze, Z.; Aranyi, P., 1999:
In vivo testing of potential anti-amnesic therapeutic agents by transgenic animal model

Andersson, T.; Bruze, M.; Björkner, B., 1999:
In vivo testing of the protection of gloves against acrylates in dentin-bonding systems on patients with known contact allergy to acrylates

Andersson, T.; Bruze, M., 1999:
In vivo testing of the protective efficacy of gloves against allergen-containing products using an open chamber system

Mitjans, F.; Meyer, T.; Fittschen, C.; Goodman, S.; Jonczyk, A.; Marshall, J.F.; Reyes, G.; Piulats, J., 2000:
In vivo therapy of malignant melanoma by means of antagonists of alphav integrins

Xue, R.; Van Zijl, P.C.M.; Crain, B.J.; Solaiyappan, M.; Mori, S., 1999:
In vivo three-dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging

Sacks, M.S.; Vorp, D.A.; Raghavan, M.L.; Federle, M.P.; Webster, M.W., 1999:
In vivo three-dimensional surface geometry of abdominal aortic aneurysms

Merlini, P.A.; Ardissino, D.; Rosenberg, R.D.; Colombi, E.; Agricola, P.; Oltrona, L.; Ottani, F.; Galvani, M.; Bauer, K.A.; Bottasso, B.; Bertocchi, F.; Mannucci, P.M., 2000 :
In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectoris

Stroman, P.W.; Dorvil, J.C.aude; Marois, Y.; Poddevin, N.; Guidoin, R., 1999:
In vivo time course studies of the tissue responses to resorbable polylactic acid implants by means of MRI

Koike, N.; Hayakawa, N.; Tokuda, K.; Nishimiya, K.; Saito, K.; Stumpf, W., E., 2002:
In vivo time-course of receptor binding in the parathyroid gland of the vitamin D analogue (3H)1,25-dihydroxy-22-oxavitamin D3 compared with (3H)1,25-dihydroxyvitamin D3, determined by micro-autoradiography

Das, T.; Payer, B.; Cayouette, M.; Harris, W.A., 2003:
In vivo time-lapse imaging of cell divisions during neurogenesis in the developing zebrafish retina

Walsh, M.K.; Lichtman, J.W., 2003:
In vivo time-lapse imaging of synaptic takeover associated with naturally occurring synapse elimination

Streif, Jörg.U.G.; Herold, V.; Szimtenings, M.; Lanz, T.E.; Nahrendorf, M.; Wiesmann, F.; Rommel, E.; Haase, A., 2003:
In vivo time-resolved quantitative motion mapping of the murine myocardium with phase contrast MRI

Dedieu, V.; Finat-Duclos, F.; Renou, J.P.; Joffre, F.; Vincensini, D., 1999:
In vivo tissue extracellular volume fraction measurement by dynamic spin-lattice MRI relaxometry: application to the characterization of muscle fiber types

Buerk, D.G.; Tsai, A.G.; Intaglietta, M.; Johnson, P.C., 1998:
In vivo tissue pO2 measurements in hamster skinfold by recessed pO2 microelectrodes and phosphorescence quenching are in agreement

Zhang, D.P.ng; Chen Shang Wu, 2001:
In vivo tissue-dependent abscisic acid specific-binding proteins with high affinity in cytosol of developing apple fruits

Mathy, F-X.; Denet, A-R.; Vroman, B.; Clarys, P.; Barel, A.; Verbeeck, R.K.; Préat, V., 2003:
In vivo tolerance assessment of skin after insertion of subcutaneous and cutaneous microdialysis probes in the rat

Suen, J.L.ng; Chuang, Y.H.i; Chiang, B.L.en, 2002:
In vivo tolerance breakdown with dendritic cells pulsed with U1A protein in non-autoimmune mice: The induction of a high level of autoantibodies but not renal pathological changes

Fernández-Pastor, Bña.; Meana, J.Javier., 2002:
In vivo tonic modulation of the noradrenaline release in the rat cortex by locus coeruleus somatodendritic alpha(2)-adrenoceptors

Kuppusamy, P.; Wang, P.; Shankar, R.A.; Ma, L.; Trimble, C.E.; Hsia, C.J.C.; Zweier, J.L., 1998:
In vivo topical EPR spectroscopy and imaging of nitroxide free radicals and polynitroxyl-albumin

Robosky, L.C.; Robertson, D.G.; Baker, J.David.; Rane, S.; Reily, M.D., 2002:
In vivo toxicity screening programs using metabonomics

Hojo, Y.; Hashimoto, I.; Miyamoto, Y.; Kawazoe, S.; Mizutani, T., 2000:
In vivo toxicity, lipid peroxide lowering, and glutathione, ascorbic acid and copper elevation induced in mouse liver by low dose of oxine-copper, a fungicide

Chen, C.-Lin; Venkatachalam, T., K.; Waurzyniak, B.; Chelstrom, L.; Uckun, F., M., 2001:
In vivo toxicity, pharmacokinetic features and tissue distribution of N-(2-(2,5-dimethoxyphenylethyl))-N'-(2-(5-bromopyridyl))-thiourea (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase

Uckun, F.M.; Qazi, S.; Pendergrass, S.; Lisowski, E.; Waurzyniak, B.; Chen, C-Lin.; Venkatachalam, T.K., 2002:
In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice

Ferrari, A.; Hannouche, D.; Oudina, K.; Bourguignon, M.; Meunier, A.; Sedel, L.; Petite, H., 2001:
In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye

Tang, Y.; Shah, K.; Messerli, S.M.; Snyder, E.; Breakefield, X.; Weissleder, R., 2003:
In vivo tracking of neural progenitor cell migration to glioblastomas

Plett, P.Artur.; Frankovitz, S.M.; Orschell-Traycoff, C.M., 2002:
In vivo trafficking, cell cycle activity, and engraftment potential of phenotypically defined primitive hematopoietic cells after transplantation into irradiated or nonirradiated recipients

Pautler, R.G.; Mongeau, R.; Jacobs, R.E., 2003:
In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI)

Bass, L.A.; Wang, M.; Welch, M.J.; Anderson, C.J., 2000:
In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver

Furuta, T.; Tomioka, R.; Taki, K.; Nakamura, K.; Tamamaki, N.; Kaneko, T., 2001:
In vivo transduction of central neurons using recombinant Sindbis virus: Golgi-like labeling of dendrites and axons with membrane-targeted fluorescent proteins

Marley, W.S.; Wilke, L.; Bowen, R.A., 1999:
In vivo transfection and expression of exogenous genes within proximal tubules of rats

Zhang, G.; Selzer, M.E., 2001:
In vivo transfection of lamprey brain neurons by gene gun delivery of DNA

Kawahira, Y.; Sawa, Y.; Nishimura, M.; Sakakida, S.; Ueda, H.; Kaneda, Y.; Matsuda, H., 1998:
In vivo transfer of a beta2-adrenergic receptor gene into the pressure-overloaded rat heart enhances cardiac response to beta-adrenergic agonist

Lukacs, K.V.; Porter, C.D.; Pardo, O.E.; Oakley, R.E.; Steel, R.M.; Judd, D.V.; Browning, J.E.; Geddes, D.M.; Alton, E.W., 1999:
In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient mice

Shiota, G.; Kunisada, T.; Oyama, K.; Udagawa, A.; Nomi, T.; Tanaka, K.; Tsutsumi, A.; Isono, M.; Nakamura, T.; Hamada, H.; Sakatani, T.; Sell, S.; Sato, K.; Ito, H.; Kawasaki, H., 2000:
In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats

Fernandes, J.; Tardif, G.; Martel-Pelletier, J.; Lascau-Coman, V.; Dupuis, M.; Moldovan, F.; Sheppard, M.; Krishnan, B.R.; Pelletier, J.P., 1999:
In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression

Heddle, J., A.; Dean, S.; Nohmi, T.; Boerrigter, M.; Casciano, D.; Douglas, G., R.; Glickman, B., W.; Gorelick, N., J.; Mirsalis, J., C.; Martus, H.-Jorg; Skopek, T., R.; Thybaud, V.; Tindall, K., R.; Yajima, N., 2000:
In vivo transgenic mutation assays

Thybaud, V.; Dean, S.; Nohmi, T.; D.B.er, J.; Douglas, G.R.; Glickman, B.W.; Gorelick, N.J.; Heddle, J.A.; Heflich, R.H.; Lambert, I.; Martus, H.J.rg; Mirsalis, J.C.; Suzuki, T.; Yajima, N., 2003:
In vivo transgenic mutation assays

Martinet, N.; Bonnard, L.; Regnault, Véronique.; Picard, E.; Burke, L.; Siat, Jëlle.; Grosdidier, G.; Martinet, Y.; Vignaud, J-Michel., 2003:
In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer

White, P.M.; Anderson, D.J., 1999:
In vivo transplantation of mammalian neural crest cells into chick hosts reveals a new autonomic sublineage restriction

Messier, T.L.; O'Neill, J.Patrick.; Hou, S-Mei.; Nicklas, J.A.; Finette, B.A., 2003:
In vivo transposition mediated by V(D)J recombinase in human T lymphocytes

Kraiss, A.; Schlör, S.; Reidl, J., 1998:
In vivo transposon mutagenesis in Haemophilus influenzae

Vollmer, D.L.; Szlek, M.A.; Kolb, K.; Lloyd, L.B.; Parkinson, T.M., 2003:
In vivo transscleral iontophoresis of amikacin to rabbit eyes

Fischer, S.; Liu, M.; MacLean, A.A.; de Perrot, M.; Ho, M.; Cardella, J.A.; Zhang, X.M.; Bai, X.H.; Suga, M.; Imai, Y.; Keshavjee, S., 2001:
In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia-reperfusion injury and improves early posttransplant graft function in the rat

Nasreen, M.; Ueno, T.; Saito, F.; Takahama, Y., 2003:
In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla

Smorenburg, S., M.; Vink, R.; Te-Lintelo, M.; Tigchelaar, W.; Maas, A.; Buller, H., R.; Van-Noorden, C.-Jf, 1999:
In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis

Massheimer, V.; Boland, R.; De-Boland, A.R., 1999:
In vivo treatment with calcitriol (1,25(OH)2D3) reverses age-dependent alterations of intestinal calcium uptake in rat enterocytes

Zimbelman, J.; Thurman, G.; Leavey, P.J.; Ellison, M.C.; Ambruso, D.R., 2002:
In vivo treatment with granulocyte colony-stimulating factor does not delay apoptosis in human neutrophils by increasing the expression of the vacuolar proton ATPase

Leavey, P.J.; Sellins, K.S.; Thurman, G.; Elzi, D.; Hiester, A.; Silliman, C.C.; Zerbe, G.; Cohen, J.J.; Ambruso, D.R., 1998:
In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro

Diehl, L.; van Mierlo, G.J.D.; den Boer, A.T.; van der Voort, E.; Fransen, M.; van Bostelen, L.; Krimpenfort, P.; Melief, C.J.M.; Mittler, R.; Toes, R.E.M.; Offringa, R., 2002:
In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway

Cooke, S.P.; Pedley, R.B.rbara; Boden, R.; Begent, R.H.J.; Chester, K.A., 2002:
In vivo tumor delivery of a recombinant single-chain Fv::Tumor necrosis factor: A fusion protein

Fluiter, K.; ten Asbroek, A.L.M.A.; de Wissel, M.B.; Jakobs, M.E.; Wissenbach, M.; Olsson, Håkan.; Olsen, O.; Oerum, H.; Baas, F., 2003:
In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides

Ahmed, C.M.; Sugarman, B.J.; Johnson, D.E.; Bookstein, R.E.; Saha, D.P.; Nagabhushan, T.L.; Wills, K.N., 1999:
In vivo tumor suppression by adenovirus-mediated interferon alpha2b gene delivery

Kalo, M.S.; Yu, H.H.; Pasquale, E.B., 2001:
In vivo tyrosine phosphorylation sites of activated ephrin-B1 and ephB2 from neural tissue

Ruppert, M.; Cadosch, J.; Guindy, J.; Case, D.; Zappa, U., 2002:
In vivo ultrasonic debridement forces in bicuspids: a pilot study

Plett, M.I.; Beach, K.W.; Dunmire, B.; Brown, K.G.; Primozich, J.F.; Strandness, E.Jr, 2001:
In vivo ultrasonic measurement of tissue vibration at a stenosis: A case study

Siddiqi, T.A.; Miodovnik, M.; Meyer, R.A.; O'brien, W.D.Jr, 1999:
In vivo ultrasonographic exposimetry: Human tissue-specific attenuation coefficients in the gynecologic examination

Cantorna, M.T.; Humpal-Winter, J.; DeLuca, H.F., 2000:
In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3)

Boado, R.J.; Wu, D.; Windisch, M., 1999:
In vivo upregulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived peptides

Wiesenack, C.; Wiesner, G.; Keyl, C.; Gruber, M.; Philipp, A.; Ritzka, M.; Prasser, C.; Taeger, K., 2002:
In vivo uptake and elimination of isoflurane by different membrane oxygenators during cardiopulmonary bypass

Tsimikas, S.; Shortal, B.P.; Witztum, J.L.; Palinski, W., 2000:
In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression

O'Connell, B.C.; Redman, R.S.; Zheng, C., 1998:
In vivo use of adenoviral vectors: effects on salivary gland structure

Ustün, C.; Beksac, M.; Dalva, K.; Koc, H.; Konuk, N.; Ilhan, O.; Ozcan, M.; Topcuoglu, P.; Sertkaya, D.; Hayran, M., 2002:
In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

Ku, J.P.; Draney, M.T.; Arko, F.R.; Lee, W.A.thony; Chan, F.P.; Pelc, N.J.; Zarins, C.K.; Taylor, C.A., 2002:
In vivo validation of numerical prediction of blood flow in arterial bypass grafts

Zhou, Y.; Kassab, G.S.; Molloi, S., 2002:
In vivo validation of the design rules of the coronary arteries and their application in the assessment of diffuse disease

Lambert, D.M.; Mamer, O.A.; Akerman, B.R.; Choinière, L.; Gaudet, D.; Hamet, P.; Treacy, E.P., 2001:
In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene

Wong, A.H.; Waugh, J.M.; Amabile, P.G.; Yuksel, E.; Dake, M.D., 2002:
In vivo vascular engineering: directed migration of smooth muscle cells to limit neointima

Shah, A.S.; White, D.C.; Emani, S.; Kypson, A.P.; Lilly, R.E.; Wilson, K.; Glower, D.D.; Lefkowitz, R.J.; Koch, W.J., 2001:
In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction

Cagnin, A.; Myers, R.; Gunn, R., N.; Lawrence, A., D.; Stevens, T.; Kreutzberg, G., W.; Jones, T.; Banati, R., B., 2001:
In vivo visualization of activated glia by (11C) (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion

Yamamoto, T.; Hayashi, K.; Matsuda, H.; Kubota, E.; Tanaka, H.; Ogasawara, Y.; Nakamoto, H.; Suzuki, H.; Saruta, T.; Kajiya, F., 2001:
In vivo visualization of angiotensin II- and tubuloglomerular feedback-mediated renal vasoconstriction

Bumann, D., 2001:
In vivo visualization of bacterial colonization, antigen expression, and specific T-cell induction following oral administration of live recombinant Salmonella enterica serovar Typhimurium

Barone, C.M.; Jimenez, D.F.; Huxley, V.H.; Yang, X.F., 2000:
In vivo visualization of cerebral microcirculation in systemic thermal injury

Van Teijlingen, M.E.; Borgdorff, P.; Van Wijhe, M.H.; Van Lambalgen, T.A.; Wee, P.M.; Tangelder, G.J., 2000:
In vivo visualization of hemodialysis-induced alterations in leukocyte-endothelial interactions

Marangos, N.; Illing, R.B.njamin; Krueger, J.; Laszig, R., 2001:
In vivo visualization of the cochlear nerve and nuclei with fluorescent axonal tracers

Masai, K.; Maruyama, J-ichi.; Nakajima, H.; Kitamoto, K., 2003:
In vivo visualization of the distribution of a secretory protein in Aspergillus oryzae hyphae using the RntA-EGFP fusion protein

Crespi, Francesco, 2002:
In vivo voltammetry and concomitant electrophysiology at a single micro-biosensor to analyse ischaemia, depression and drug dependence

Yavich, L.; Tiihonen, J., 2000:
In vivo voltammetry with removable carbon fibre electrodes in freely-moving mice: Dopamine release during intracranial self-stimulation

Schwarcz, A.; Berente, Z.; Osz, E.; Doczi, T., 2001:
In vivo water quantification in mouse brain at 9.4 Tesla in a vasogenic edema model

Wiskott, H.W.A.selm; Perriard, J.; Scherrer, S.S.; Dieth, S.; Belser, U.C., 2002:
In vivo wear of three types of veneering materials using implant-supported restorations: A method evaluation

Karahan, S.; Kincaid, S.Alan.; Lauten, S.Dorothy.; Wright, J.Carroll., 2002:
In vivo whole body and appendicular bone mineral density in rats: a dual energy X-ray absorptiometry study

Freymond, D.; Dériaz, O.; Frascarolo, P.; Reiz, S.; Jéquier, E.; Urwyler, A., 2000:
In vivo whole-body resting energy expenditure and insulin action in human malignant hyperthermia

Cang, J.; Isaacson, J.S., 2003:
In vivo whole-cell recording of odor-evoked synaptic transmission in the rat olfactory bulb

Irving, T.C.; Maughan, D.W., 2000:
In vivo x-ray diffraction of indirect flight muscle from Drosophila melanogaster

Morón, Víctor.Gabriel.; Rueda, P.; Sedlik, C.; Leclerc, C., 2003:
In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway

Chen, H.H.; Castanotto, D.; LeBon, J.M.; Rossi, J.J.; Riggs, A.D., 2000:
In vivo, high-resolution analysis of yeast and mammalian RNA-protein interactions, RNA structure, RNA splicing and ribozyme cleavage by use of terminal transferase-dependent PCR

Hoydu, A.K.; Kitano, Y.; Kriss, A.; Hensley, H.; Bergey, P.; Flake, A.; Hubbard, A.; Leigh, J.S.Jr, 2000:
In vivo, in utero microscopic magnetic resonance imaging: Application in a rat model of diaphragmatic hernia

Margrie, T.W.; Brecht, M.; Sakmann, B., 2002:
In vivo, low-resistance, whole-cell recordings from neurons in the anaesthetized and awake mammalian brain

Lees, G.J.; Leong, W., 2001:
In vivo, the direct and seizure-induced neuronal cytotoxicity of kainate and AMPA is modified by the non-competitive antagonist, GYKI 52466

Bianchi, J.; Goggins, W.; Rudolph, M., 2000:
In vivo, thyroid and lens surface exposure with spiral and conventional computed tomography in dental implant radiography

Ansel, K.M.; McHeyzer-Williams, L.J.; Ngo, V.N.; McHeyzer-Williams, M.G.; Cyster, J.G., 1999:
In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines

Famulok, M.; Verma, S., 2002:
In vivo-applied functional RNAs as tools in proteomics and genomics research

O'Hara, T.; Hayes, S.; Davis, J.; Devane, J.; Smart, T.; Dunne, A., 2001:
In vivo-in vitro correlation (IVIVC) modeling incorporating a convolution step

Sanchez, E.; Baro, M.; Soriano, I.; Perera, A.; Evora, C., 2001:
In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants

Negrin, C.M.; Delgado, A.; Llabrés, M.; Evora, C., 2001:
In vivo-in vitro study of biodegradable methadone delivery systems

Handfield, M.; Lehoux, D.E.; Sanschagrin, F.; Mahan, M.J.; Woods, D.E.; Levesque, R.C., 2000:
In vivo-induced genes in Pseudomonas aeruginosa

Deas, O.; Angevin, E.; Cherbonnier, C.; Senik, A.; Charpentier, B.; Levillain, J.P.ul; Oosterwijk, E.; Hirsch, F.; Durrbach, A., 2002:
In vivo-targeted gene delivery using antibody-based nonviral vector

Wilding, E.L., 2000:
In what way does the parietal ERP old/new effect index recollection?

Partridge, M.R., 2000:
In what way may race, ethnicity or culture influence asthma outcomes?

Land, M., F.; Hayhoe, M., 2001:
In what ways do eye movements contribute to everyday activities?

Birken, C.S.; Parkin, P.C., 1999:
In which journals will pediatricians find the best evidence for clinical practice?

Parkin, P., C.; Birken, C., 2000:
In which journals will pediatricians find the best evidence for clinical practice? In reply

Mo, C.; Milla, P.; Athenstaedt, K.; Ott, R.; Balliano, G.; Daum, G.; Bard, M., 2003:
In yeast sterol biosynthesis the 3-keto reductase protein (Erg27p) is required for oxidosqualene cyclase (Erg7p) activity

Corral-Debrinski, M.; Blugeon, C.; Jacq, C., 2000:
In yeast, the 3' untranslated region or the presequence of ATM1 is required for the exclusive localization of its mRNA to the vicinity of mitochondria

Leak, F.W.; Tove, S.; Parks, L.W., 1999:
In yeast, upc2-1 confers a decrease in tolerance to LiCl and NaCl, which can be suppressed by the P-type ATPase encoded by ENA2

Shinomiya, T.; Shinomiya, K.; Orimoto, C.; Minami, T.; Tohno, Y.; Yamada, M.O.i, 1998:
In- and out-flows of elements in bones embedded in reference soils

Fuster, D.; Navasa, M.; Pons, F.; Vidal-Sicart, S.; Mateos, J.J.; Lomeña, F.; Rodes, J.; Herranz, R., 1999:
In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin

Ogawa, Y.; Uetani, M.; Aziz, A.; Hayashi, K., 2000:
In-111-labeled leukocyte scintigraphy in postoperative joint infection

Wang, S-Jen.; Tsai, S-Chuan.; Chen, G-Hum.; Lan, J-Liang.; Yen, T-Chen., 2002:
In-111-labeled platelet scintigraphies in patients with chronic hepatitis C

Parodi, K.; Enghardt, W.; Haberer, T., 2002:
In-beam PET measurements of beta+ radioactivity induced by proton beams

Hviid, T.Vauvert., 2002:
In-cell PCR method for specific genotyping of genomic DNA from one individual in a mixture of cells from two individuals: a model study with specific relevance to prenatal diagnosis based on fetal cells in maternal blood

Goncalves, F.L.T.; Ramos, A.M.; Freitas, S.; Dias, M.A.S.lva; Massambani, O., 2002:
In-cloud and below-cloud numerical simulation of scavenging processes at Serra do Mar region, SE Brazil

Beard, N.P.; Zhang, C-Xuan.; deMello, A.J., 2003:
In-column field-amplified sample stacking of biogenic amines on microfabricated electrophoresis devices

Sikkink, S.K.; Liloglou, T.; Maloney, P.; Gosney, J.R.; Field, J.K., 2003:
In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree

Au, J.S.K.; Law, C.K.; Foo, W.; Lau, W.H., 2003:
In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: Prognostic homogeneity and proposed refinements

Jordan, N.D.; Bassett, D.C.; Olley, R.H.; Smith, N.G., 2001:
In-depth morphological changes and embrittlement near the wear surface of UHMWPE inserts from uncemented hip systems

Melnick, A.; Ahmad, K.F.; Arai, S.; Polinger, A.; Ball, H.; Borden, K.L.; Carlile, G.W.; Prive, G.G.; Licht, J.D., 2000:
In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions

Huang, X.; Wang, S.; Peng, X., 1998:
In-depth study of serum immunoglobulin in cancer patients

Moiseenko, V.V.; Battista, J.J.; Hill, R.P.; Travis, E.L.; Van Dyk, J., 2000:
In-field and out-of-field effects in partial volume lung irradiation in rodents: Possible correlation between early DNA damage and functional endpoints

Nistor, C.; Rose, A.; Farre, M.; Stoica, L.; Wollenberger, U.; Ruzgas, T.; Pfeiffer, D.; Barcelo, D.; Gorton, L.; Emneus, J., 2002:
In-field monitoring of cleaning efficiency in waste water treatment plants using two phenol-sensitive biosensors

Kobayashi, A.; Miyamoto, Y., 2000:
In-flight cerebral oxygen status: continuous monitoring by near-infrared spectroscopy

Gandsas, A.; Montgomery, K.; McKenas, D.; Altrudi, R.; Silva, Y., 2000:
In-flight continuous vital signs telemetry via the Internet

Cable, G.G., 2003:
In-flight hypoxia incidents in military aircraft: causes and implications for training

Booth, M.G.; Quasim, I.; Kinsella, J., 1999:
In-flight medical emergencies: Response of anaesthetists who were passengers on commercial flights

Matsumoto, K.; Goebert, D., 2001:
In-flight psychiatric emergencies

Bouia, A.; Kholti, A.; Saghi, M.; Cornelis, P., 2001:
In-frame fusion of a His-Cys motif into the Pseudomonas aeruginosa outer membrane OprI lipoprotein results in increased metal binding capacity by Escherichia coli

Kilz, S.; Budzikiewicz, H.; Waffenschmidt, S., 2002:
In-gel deglycosylation of sodiumdodecyl sulfate polyacrylamide gel electrophoresis-separated glycoproteins for carbohydrate estimation by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Thevis, M.; Ogorzalek Loo, R.R.; Loo, J.A., 2003:
In-gel derivatization of proteins for cysteine-specific cleavages and their analysis by mass spectrometry

Witte, C.P.; Medina-Escobar, N., 2001:
In-gel detection of urease with nitroblue tetrazolium and quantification of the enzyme from different crop plants using the indophenol reaction

Harrison, M.J.; Kushner, K.E.; Benzies, K.; Kimak, C.; Jacobs, P.; Mitchell, B.F., 2001:
In-home nursing care for women with high-risk pregnancies: Outcomes and cost

Meneveau, N.; Ming, L.Pin.; Séronde, M.France.; Mersin, N.; Schiele, Fçois.; Caulfield, F.; Bernard, Y.; Bassand, J-Pierre., 2003 :
In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy

Nijland, F.; Kamp, O.; Verhorst, P.M.J.; D.V.ogt, W.G.; Visser, C.A., 2001:
In-hospital and long-term prognostic value of viable myocardium detected by dobutamine echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular systolic dysfunction

Gruberg, L.; Hong, M.K.; Mehran, R.; Mintz, G.S.; Kornowski, R.; Lansky, A.J.; Kent, K.M.; Pichard, A.D.; Satler, L.F.; Dangas, G.; Wu, H.; Stone, G.W.; Leon, M.B., 1999:
In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site

Shihara, M.; Tsutsui, H.; Tsuchihashi, M.; Tada, H.; Kono, S.; Takeshita, A., 2002:
In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction

Skrifvars, M.B.; Castren, M.; Kurola, J.; Rosenberg, P.H., 2002:
In-hospital cardiopulmonary resuscitation: Organization, management and training in hospitals of different levels of care

de Vos, R.; Koster, R.W.; D.H.an, R.J.; Oosting, H.; van der Wouw, P.A.; Lampe-Schoenmaeckers, A.J., 1999:
In-hospital cardiopulmonary resuscitation: prearrest morbidity and outcome

Kwan, J.; Sandercock, P., 2003:
In-hospital care pathways for stroke: a Cochrane systematic review

Arceo, A.; Urban, P.; Dorsaz, P-André.; Chatelain, P.; Verin, V.; Suilen, C.; Rombaut, E.; Chevrolet, J-Claude., 2003:
In-hospital complications of percutaneous intraaortic balloon counterpulsation

Brox, A.C.; Filion, K.B.; Zhang, X.; Pilote, L.; Obrand, D.; Haider, S.; Azoulay, A.; Eisenberg, M.J., 2003:
In-hospital cost of abdominal aortic aneurysm repair in Canada and the United States

Goldacre, M.J.; Griffith, M.; Gill, L.; Mackintosh, A., 2002:
In-hospital deaths as fraction of all deaths within 30 days of hospital admission for surgery: analysis of routine statistics

Santini, M.; Colivicchi, F., 2002:
In-hospital management of syncope: the European perspective

Barker, F.G.; Amin-Hanjani, S.; Butler, W.E.; Ogilvy, C.S.; Carter, B.S., 2003:
In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume

Patil, S.P.; Krishnan, J.A.; Lechtzin, N.; Diette, G.B., 2003:
In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease

Haase, K.K.; Schiele, R.; Wagner, S.; Fischer, F.; Burczyk, U.; Zahn, R.; Schuster, S.; Senges, J., 2000:
In-hospital mortality of elderly patients with acute myocardial infarction: Data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry

Andrikopoulos, G.K.; Richter, D.J.; Dilaveris, P.E.; Pipilis, A.; Zaharoulis, A.; Gialafos, J.E.; Toutouzas, P.K.; Chimonas, E.T., 2001:
In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study

Empana, J.P.; Subtil, D.; Truffert, P., 2003:
In-hospital mortality of newborn infants born before 33 weeks of gestation depends on the initial level of neonatal care: The EPIPAGE study

Oe, K.; Shimizu, M.; Ino, H.; Yamaguchi, M.; Terai, H.; Hayashi, K.; Kiyama, M.; Sakata, K.; Hayashi, T.; Inoue, M.; Kaneda, T.; Mabuchi, H., 2003:
In-hospital outcome in octogenarians with acute coronary syndrome undergoing emergent coronary angiography

Jamal, S.M.; Shrive, F.M.; Ghali, W.A.; Knudtson, M.L.; Eisenberg, M.J., 2003 :
In-hospital outcomes after percutaneous coronary intervention in Canada: 1992/93 to 2000/01

Clini, E.; Foglio, K.; Bianchi, L.; Porta, R.; Vitacca, M.; Ambrosino, N., 2001:
In-hospital short-term training program for patients with chronic airway obstruction

Epstein, A.E.; Powell, J.; Yao, Q.; Ocampo, C.; Lancaster, S.; Rosenberg, Y.; Cannom, D.S.; Herre, J.M.; Greene, H.L.on; Avid Investigators, 1999:
In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: Results from the AVID registry

Evans, G.; Roversi, P.; Bricogne, G., 2000:
In-house low-resolution X-ray crystallography

Debreczeni, J.E.; Bunkoczi, G.; Ma, Q.; Blaser, H.; Sheldrick, G.M., 2003:
In-house measurement of the sulfur anomalous signal and its use for phasing

Debreczeni, J.E.; Bunkóczi, Gábor.; Girmann, B.; Sheldrick, G.M., 2003:
In-house phase determination of the lima bean trypsin inhibitor: a low-resolution sulfur-SAD case

Fulda, G.J.; Tinkoff, G.H.; Giberson, F.; Rhodes, M., 2002:
In-house trauma surgeons do not decrease mortality in a level I trauma center

Dailianis, A.E.; Hughes, D., 2002:
In-house validation study for salmonella unique testing of juice (modification of AOAC official method 2000.07)

Demarest, G.B.; Scannell, G.; Sanchez, K.; Dziwulski, A.; Qualls, C.; Schermer, C.R.; Albrecht, R.M., 1999:
In-house versus on-call attending trauma surgeons at comparable level I trauma centers: a prospective study

Apruzzese, F.B.lke, S.; Diosady, L., 2000:
In-line colour and composition monitoring in the extrusion cooking process

Hilmi, A.; Luong, J.H., 2000:
In-line coupling capillary electrochromatography with amperometric detection for analysis of explosive compounds

Colombo, C.; Van Den Berg, C.M.G., 1998:
In-line deoxygenation for flow analysis with voltammetric detection

Martin, O.; Averous, L.; Della Valle, G., 2003:
In-line determination of plasticized wheat starch viscoelastic behavior: Impact of processing

Baeza, J.A.; Gabriel, D.; Lafuente, J., 2002:
In-line fast OUR (oxygen uptake rate) measurements for monitoring and control of WWTP

Spanne, P.; Raven, C.; Snigireva, I.; Snigirev, A., 1999:
In-line holography and phase-contrast microtomography with high energy x-rays

Kunac, D.L.; Ball, P.A.; Broadbent, R.S., 1999:
In-line intravenous filtration in neonates: Help not hindrance

Zeiler, T.; Kretschmer, V., 1999:
In-line leukocyte depletion of thrombocyte apheresis concentrates

Bolliger, S.; Zeng, Y.; Windhab, E.J., 1999:
In-line measurement of tempered cocoa butter and chocolate by means of near-infrared spectroscopy

Rantanen, J.; Rasanen, E.; Tenhunen, J.; Kansakoski, M.; Mannermaa, J.P.kka; Yliruusi, J., 2000:
In-line moisture measurement during granulation with a four-wavelength near infrared sensor: An evaluation of particle size and binder effects

Lippemeier, S.; Hintze, R.; Vanselow, K.H.; Hartig, P.; Colijn, F., 2001:
In-line recording of PAM fluorescence of phytoplankton cultures as a new tool for studying effects of fluctuating nutrient supply on photosynthesis

Manthous, C.A.; Khamiees, M., 2000:
In-line suction catheters may impede aerosol delivery to patients receiving mechanical ventilation

Bolliger, S.; Closs, C.; Zeng, Y.; Windhab, E., 1998:
In-line use of near infrared spectroscopy to measure structure parameters of frozen model sorbet

Malmqvist, A.; Ternstrom, A.; Welander, T., 1999:
In-mill biological treatment for paper mill closure

Price, G., 2000:
In-patient detoxification after GHB dependence

Bolzan, M.; Frigo, A.C.; Fabbris, M.L.; Rausa, G., 1998:
In-patient satisfaction with hospital hygienic services in Italy

Deisenhammer, E.A.; Decol, C.; Honeder, M.; Hinterhuber, H.; Fleischhacker, W.W., 2000:
In-patient suicide in psychiatric hospitals

Yamamoto, T.; Matsumura, A.; Yamamoto, K.; Kumada, H.; Shibata, Y.; Nose, T., 2002:
In-phantom two-dimensional thermal neutron distribution for intraoperative boron neutron capture therapy of brain tumours

Nakayama, H.; Shibuya, M.; Yamada, M.; Suzuki, H.; Arakawa, M.; Homma, I., 1998:
In-phase chest wall vibration decreases dyspnea during arm elevation in chronic obstructive pulmonary disease patients

Zheng, W.M.u; Wu, F., 2003 :
In-phase implies large likelihood for independent codon model: Distinguishing coding from non-coding sequences

Achenbach, S.; Ropers, D.; Holle, J.; Muschiol, G.; Daniel, W.G.; Moshage, W., 2000:
In-plane coronary arterial motion velocity: measurement with electron-beam CT

Haupt, C.I.; Kiefer, A.P.; Maudsley, A.A., 1998:
In-plane motion correction for MR spectroscopic imaging

Dulkadiroglu, H.; Eremektar, G.; Dogruel, S.; Uner, H.; Germirli-Babuna, F.; Orhon, D., 2002:
In-plant control applications and their effect on treatability of a textile mill wastewater

Laviana, L.; Llorente, I.; Bayod, M.; Blanco, D., 2003:
In-process control of midazolam synthesis by HPLC

Ettinger, A.; Ostroff, R.; Brien, J.; Polisky, B., 2002:
In-process monitoring of protein purification with thin film silicon sensor technology

Enzenhofer, H.J.; Cronkite, G., 1998:
In-river accessory equipment for fixed-location hydroacoustic systems

Roberts, D., 2002:
In-season physiological and biochemical status of reforestation workers

Cobb, J.E.; Claremont, D.J., 2002:
In-shoe measurement of plantar blood flow in diabetic subjects: results of a preliminary clinical evaluation

Klopman, G.; Chakravarti, S.K.; Harris, N.; Ivanov, J.; Saiakhov, R.D., 2003:
In-silico screening of high production volume chemicals for mutagenicity using the MCASE QSAR expert system

Park, H.; Won, M.S.ok; Cheong, C.; Shim, Y.B., 2002:
In-situ ESR detection of radical species of p-benzoquinone in aqueous media

Wang, Z.; Liu, D.; Dong, S., 2001:
In-situ FTIR study on adsorption and oxidation of native and thermally denatured calf thymus DNA at glassy carbon electrodes

Blackley, H.K.; Sanders, G.H.; Davies, M.C.; Roberts, C.J.; Tendler, S.J.; Wilkinson, M.J., 2000:
In-situ atomic force microscopy study of beta-amyloid fibrillization

Hauttmann, S.; Mueller, J., 2001:
In-situ biomass characterisation by impedance spectroscopy using a full-bridge circuit

Soloway, D.A.; Nahir, M.; Billowits, M.E.; Whyte, L.G., 2001:
In-situ bioremediation of diesel-contaminated soil in Canada's Arctic territory: A case study at the Whitehorse International Airport, Yukon territory

Keller, J.M.; Brusseau, M.L., 2003:
In-situ characterization of soil-water content using gas-phase partitioning tracer tests: Field-scale evaluation

Yan, L.; Thompson, K.E.; Valsaraj, K.T.; Reible, D.D., 2003:
In-situ control of DNAPL density using polyaphrons

Sng, M.T.ang; Ng, W.F.ng, 1999:
In-situ derivatisation of degradation products of chemical warfare agents in water by solid-phase microextraction and gas chromatographic-mass spectrometric analysis

Matthiesen, L.; Khademi, M.; Ekerfelt, C.; Berg, G.; Sharma, S.; Olsson, T.; Ernerudh, J., 2003:
In-situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy

Krom Michael, D.; Mortimer Robert, J.G.; Poulton Simon, W.; Hayes Peter; Davies Ian, M.; Davison William; Zhang Hao, 2002:
In-situ determination of dissolved iron production in recent marine sediments

Sun-Yao; Chen-Ju-Fa; Yin-Li; Song-Yun-Li, 2000:
In-situ determination of sediment oxygen demand in cultivation ponds

Sun, Q.; Tran, M.; Smith, B.; Winefordner, J.D., 2000:
In-situ evaluation of barrier-cream performance on human skin using laser-induced breakdown spectroscopy

Khan, S.H.; Aguirre, A.; Bobek, L.A., 1998:
In-situ hybridization localized MUC7 mucin gene expression to the mucous acinar cells of human and MUC7-transgenic mouse salivary glands

Cao, Y.; Kopplow, K.; Liu, G.Y., 2000:
In-situ immuno-PCR to detect antigens

Rieger, L.; Siegrist, H.; Winkler, S.; Saracevic, E.; Votava, R.; Nadler, J., 2002:
In-situ measurement of ammonium and nitrate in the activated sludge process

Otálora, F.; Gavira, J.A.; Capelle, B.; García-Ruiz, J.M., 1999:
In-situ measurement of rocking curves during lysozyme crystal growth

Lu, J.; Zenobi, R., 2000:
In-situ monitoring of protein labeling reactions by matrix-assisted laser desorption/ionization mass spectrometry

Arkhipkin, A.I.; Middleton, D.A.J., 2003:
In-situ monitoring of the duration of embryonic development in the squid Loligo gahi (Cephalopoda: Loliginidae) on the Falkland shelf

Arnold, S.Alison.; Crowley, J.; Woods, N.; Harvey, L.M.; McNeil, B., 2003:
In-situ near infrared spectroscopy to monitor key analytes in mammalian cell cultivation

Brulls, M.; Folestad, S.; Sparen, A.; Rasmuson, A., 2003:
In-situ near-infrared spectroscopy monitoring of the lyophilization process

Schroth, M.H.; Oostrom, M.; Wietsma, T.W.; Istok, J.D., 2001:
In-situ oxidation of trichloroethene by permanganate: Effects on porous medium hydraulic properties

Sansalone, John, J., 1999:
In-situ performance of a passive treatment system for metal source control

Ahmed, F.; Stein, A.; Lye, G.J., 2001:
In-situ product removal to enhance the yield of biocatalytic reactions with competing equilibria: alpha-glucosidase catalysed synthesis of disaccharides

Wu, Y.; Hu, B.; Peng, T.; Jiang, Z., 2001:
In-situ separation of chromium(III) and chromium(VI) and sequential ETV-ICP-AES determination using acetylacetone and PTFE as chemical modifiers

Schneider, P.; Neitzel, P.L.; Osenbrueck, K.; Noubacteb, C.; Merkel, B.; Hurst, S., 2001:
In-situ treatment of radioactive mine water using reactive materials: Results of laboratory and field experiments in uranium ore mines in Germany

Miri, T.C.x, P.; Fryer, P., 2003:
In-situ visualisation of hyphal structure and arrangement in mycoprotein pastes

Steckel, H.; Rasenack, N.; Mueller, B.W., 2003:
In-situ-micronization of disodium cromoglycate for pulmonary delivery

Marquet, P.; Venisse, N.; Lacassie, E.; Lachatre, G., 2000:
In-source CID mass spectral libraries for the general unknown screening of drugs and toxicants

Letzel; Poschl; Rosenberg; Grasserbauer; Niessner, 1999:
In-source fragmentation of partially oxidized mono- and polycyclic aromatic hydrocarbons in atmospheric pressure chemical ionization mass spectrometry coupled to liquid chromatography

Buré, C.; Gobert, W.; Lelièvre, D.; Delmas, A., 2001:
In-source fragmentation of peptide aldehydes and acetals: influence of peptide length and charge state

Prati, F.; D.M.rio, C.; Moussa, I.; Reimers, B.; Mallus, M.T.resa; Parma, A.; Lioy, E.; Colombo, A., 1999:
In-stent neointimal proliferation correlatives with the amount of residual plasque burden outside the stent: An Intravascular Ultrasound Study

Chakhtoura, E.Y.; Hobson, R.W.; Goldstein, J.; Simonian, G.T.; Lal, B.K.; Haser, P.B.; Silva, M.B.; Padberg, F.T.; Pappas, P.J.; Jamil, Z., 2001:
In-stent restenosis after carotid angioplasty-stenting: incidence and management

Briguori, C.; Sarais, C.; Pagnotta, P.; Liistro, F.; Montorfano, M.; Chieffo, A.; Sgura, F.; Corvaja, N.; Albiero, R.; Stankovic, G.; Toutoutzas, C.; Bonizzoni, E.; D.M.rio, C.; Colombo, A., 2002:
In-stent restenosis in small coronary arteries: Impact of strut thickness

Bossi, I.; Klersy, C.; Black, A.J.; Cortina, R.; Choussat, R.; Cassagneau, B.; Jordan, C.; Laborde, J.C.aude; Laurent, J.P.erre; Bernies, M.; Fajadet, J.; Marco, J., 2000:
In-stent restenosis: Long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty

Bennett, M.R., 2003:
In-stent stenosis: pathology and implications for the development of drug eluting stents

Jowett, I.G., 2002:
In-stream habitat suitability criteria for feeding inanga (Galaxias maculatus)

Tokuda, Y.; Tsuchida, S.; Inouye, J.; Tanaka, Y.; Eguchi, S.; Eguchi, K.; Yoshitomi, F., 1998:
In-the-bag artificial iris implantation during cataract surgery in eyes with iris defect

Brown, M.L.; Powell, J.L.; Lucchesi, D.O., 2002:
In-transit oxytetracycline marking, nonlethal mark detection, and tissue residue depletion in yellow perch

Worm, J.; Aggerholm, A.; Guldberg, P., 2001:
In-tube DNA methylation profiling by fluorescence melting curve analysis

Rego, A.; Roley, L., 1999:
In-use barrier integrity of gloves: Latex and nitrile superior to vinyl

Yanowitz, J.; Mccormick, R.L.; Graboski, M.S., 2000:
In-use emissions from heavy-duty diesel vehicles

Strawn, J.R.; Ekhator, N.N.; Geracioti, T.D.Jr, 2001:
In-use stability of monoamine metabolites in human cerebrospinal fluid

Aubry, A.F.ancoise; Sebastian, D.; Hobson, T.; Xu, J.Q.; Rabel, S.; Xie, M.; Gray, V., 2000:
In-use testing of extemporaneously prepared suspensions of second generation non-nucleoside reversed transcriptase inhibitors in support of Phase I clinical studies

Potischman, N.; Troisi, R., 1999:
In-utero and early life exposures in relation to risk of breast cancer

Hutchison, S.J.; Glantz, S.A.; Zhu, B.Q.ng; Sun, Y.P.ng; Chou, T.M.; Chatterjee, K.; Deedwania, P.C.; Parmley, W.W.; Sudhir, K., 1998:
In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats

Raio, L.; Ghezzi, F.; di Naro, E.; Franchi, M.; Balestreri, D.; Dürig, P.; Schneider, H., 2001:
In-utero characterization of the blood flow in the Hyrtl anastomosis

Schernhammer, Eva, S., 2002:
In-utero exposures and breast cancer risk: Joint effect of estrogens and insulin-like growth factor?

Quintero, R.A.; Homsy, Y.; Bornick, P.W.; Allen, M.; Johnson, P.K., 2001:
In-utero treatment of fetal bladder-outlet obstruction by a ureterocele

Stevens, A.; Minton, R., 2001:
In-vehicle distraction and fatal accidents in England and Wales

Ghaly, A.E.; Pyke, J.B., 2001:
In-vessel bioremediation of oil-contaminated peat

Vreuls, R.J.J.; Romijn, E.; Brinkman, U.A.T., 1998:
In-vial liquid-liquid extraction with subsequent large-volume on-column infection into GC-MS for the determination of anilines in tap, surface, and wastewater

Verica, M.; Gordana, V.; Branislava, S.; Vitorovic, D.; Ivkovic, S.; Dubravka, V., 2000:
In-vitro 137Cs sorption by natural and monoionic forms of clinoptilolite

Hecke, F.; Hoehn, T.; Strauss, E.; Obladen, M.; Sonntag, J., 2001:
In-vitro activation of complement system by lactic acidosis in newborn and adults

Luna, V.A.; Roberts, M.C., 1999:
In-vitro activities of 11 antibiotics against 75 strains of Streptococcus pneumoniae with reduced susceptibilities to penicillin isolated from patients in Washington State

Miyazaki, S.; Ishii, Y.; Ohno, A.; Furuya, N.; Matsumoto, T.; Tateda, K.; Yamaguchi, K., 1999:
In-vitro activities of 11 antibiotics against vancomycin-resistant enterococci isolated in Japan

Verhaegen, J.; Verbist, L., 1999:
In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae

Croco, M.A.; Biedenbach, D.J.; Pfaller, M.A.; Doern, G.V.; Jones, R.N., 1998:
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp

Kantarcioğlu, A.S.; Yucel, A., 2003:
In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species

Giacometti, A.; Cirioni, O.; Barchiesi, F.; Scalise, G., 2000:
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics

Songca, Sandile, P., 2001:
In-vitro activity and tissue distribution of new fluorinated meso-tetrahydroxyphenylporphyrin photosensitizers

Manzor, O.; Pawlak, J.; Saravolatz, L., 1999:
In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae

Giamarellos-Bourboulis, E.J.; Grecka, P.; Tsitsika, A.; Tympanidou, C.; Giamarellou, H., 2000:
In-vitro activity of FK 037 (Cefoselis), a novel 4th generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative isolates

Wootton, M.; Bowker, K.E.; Janowska, A.; Holt, H.A.; MacGowan, A.P., 1999:
In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci

Tsakris, A.; Alexiou-Daniel, S.; Souliou, E.; Antoniadis, A., 1999:
In-vitro activity of antibiotics against Legionella pneumophila isolates from water systems

You, I.; Kariyama, R.; Zervos, M.J.; Kumon, H.; Chow, J.W., 2000:
In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus

Giacometti, A.; Cirioni, O.; Barchiesi, F.; Fortuna, M.; Scalise, G., 1999:
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa

Tallis, E.; Rudensky, B.; Attias, D.; Raveh, D.; Schlesinger, Y.; Yinnon, A.M., 1999:
In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of Gram-negative bacilli and Staphylococcus aureus

Blondeau, J.M.; Laskowski, R.; Borsos, S.; Canadian Afermenter Study Group, 1999:
In-vitro activity of cefepime and seven other antimicrobial agents against 1518 non-fermentative Gram-negative bacilli collected from 48 Canadian health care facilities

Kato, K.; Iwai, S.; Sato, T.; Harada, T.; Nakagawa, Y.; Iwanaga, H.; Ito, Y.; Takayama, T., 2002:
In-vitro activity of ciprofloxacin combined with flomoxef against Bacteroides fragilis, compared with that of ciprofloxacin combined with clindamycin

Nikolaidis, P.; Metallidis, S.; Kollaras, P.; Tsona, A.; Koumedaki, E.; Tsaousoglu, D.; Loumedaki, E., 2002:
In-vitro activity of clinafloxacin compared to ciprofloxacin against Acinetobacter baumannii strains isolated from intensive care unit patients

Del Poeta, M.; Bixel, A.S.; Barchiesi, F.; Tidwell, R.R.; Boykin, D.; Scalise, G.; Perfect, J.R., 1999:
In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp

Roblin, P.M.; Hammerschlag, M.R., 1999:
In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae

Bébéar, C.M.; Renaudin, H.; Schaeverbeke, T.; Leblanc, F.; Bébéar, C., 1999:
In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas

Thomson, K.S.; Chartrand, S.A.; Sanders, C.C.; Block, S.L., 1999:
In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance

Kitzis, M.D.; Goldstein, F.W.; Miegi, M.; Acar, J.F., 1999:
In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalis

Martínez-Martínez, L.; Pascual, A.; Suárez, A.I.; Perea, E.J., 1999:
In-vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria and Listeria monocytogenes

Tankovic, J.; Bachoual, R.; Ouabdesselam, S.; Boudjadja, A.; Soussy, C.J., 1999:
In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis

Miyashita, N.; Fukano, H.; Yoshida, K.; Niki, Y.; Matsushima, T., 2002:
In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species

Maggiolo, F.; Capra, R.; Bottura, P.; Pravettoni, G.; Migliorino, M.; Suter, F., 2000:
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus

Giacometti, A.; Cirioni, O.; Barchiesi, F.; Caselli, F.; Scalise, G., 1999:
In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates

Cirioni, O.; Giacometti, A.; Barchiesi, F.; Fortuna, M.; Scalise, G., 1999:
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii

Johnson, A.P.; Warner, M.; Speller, D.C., 1998:
In-vitro activity of sanfetrinem against isolates of Streptococcus pneumoniae and Staphylococcus aureus

Dhople, A.M.; Namba, K., 2003:
In-vitro activity of sitafloxacin (DU-6859a), either singly or in combination with rifampin analogs, against Mycobacterium leprae

Chávez, M.; Bernal, S.; Valverde, A.; Gutierrez, M.J.; Quindós, G.; Mazuelos, E.M., 1999:
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

Debrock, S.; Vander Perre, S.; Meuleman, C.; Moerman, P.; Hill, J.A.; D'Hooghe, T.M., 2002:
In-vitro adhesion of endometrium to autologous peritoneal membranes: effect of the cycle phase and the stage of endometriosis

Allorge, D.; Harlow, J.; Boulet, O.; Hayhurst, G.P.; Chowdry, J.; Roth, E.; Crewe, K.; Lo-Guidice, J.M.; Lhermitte, M.; Broly, F.; Tucker, G.T.; Ellis, S.W., 2001:
In-vitro analysis of the contribution of CYP2D6.35 to ultra-rapid metabolism

Akinshola, B.E.; Chakrabarti, A.; Onaivi, E.S., 1999:
In-vitro and in-vivo action of cannabinoids

Hossain, M.A.; Maesaki, S.; Mitsutake, K.; Kakeya, H.; Sasaki, E.; Tomono, K.; Tashiro, T.; Kohno, S., 1999:
In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans

Lee, S-Hee.; Kim, S-Ryul.; Kim, J.Sun.; Bae, H-Rahn.; Lee, C-Ho.; Kim, D-Duk., 2003:
In-vitro and in-vivo antibacterial activity evaluation of a polyurethane matrix

Candiani, G.; Abbondi, M.; Borgonovi, M.; Romanò, G.; Parenti, F. , 1999:
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic

Goswami, T.K.; Joardar, S.N.; Ram, G.C., 2000:
In-vitro and in-vivo detection of cross-reacting antigens of M. paratuberculosis and M. bovis

Fluhr, J.W.; Boesch, B.; Gloor, M.; Hoeffler, U., 1999:
In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin

Acarturk, F.; Altug, N., 2001:
In-vitro and in-vivo evaluation of a matrix-controlled bromocriptine mesilate-releasing vaginal ring

Taillefer, J.; Brasseur, N.; Van Lier, J.E.; Lenaerts, V.; L.G.rrec, D.; Leroux, J.C., 2001:
In-vitro and in-vivo evaluation of pH-responsive polymeric micelles in a photodynamic cancer therapy model

Chang, W.H.; Augustin, B.; Lane, H.Y.an; Zumbrunnen, T.; Liu, H.C.ing; Kazmi, Y.; Jann, M.W., 1999:
In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine

Hubner, R.A.; Kubota, E.; Casley, D.J.; Johnston, C.I.; Burrell, L.M., 2001:
In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat

Shibata, N.; Gao, W.; Okamoto, H.; Kishida, T.; Yoshikawa, Y.; Takada, K., 2002:
In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats

Mitsui, K.; Taki, T.; Yamada, Y.; Honda, N.; Fukatsu, H.; Yoshikawa, K., 2000:
In-vitro and in-vivo studies of the efficacy of electrochemotherapy for renal cell carcinoma

Manavathu, E.K.; Dimmock, J.R.; Vashishtha, S.C.; Cutright, J.; Chandrasekar, P.H., 1998:
In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone

Sangare, L.; Morisset, R.; Ravaoarinoro, M., 1999:
In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline

Ives, T.J.; Schwab, U.E.; Ward, E.Stacy.; Hall, I.H., 2003:
In-vitro anti-inflammatory and immunomodulatory effects of grepafloxacin in zymogen A- or Staphylococcus aureus-stimulated human THP-1 monocytes

Muleya, J.S.; Nakaichi, M.; Taura, Y.; Yamaguchi, R.; Nakama, S., 1999:
In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines

Soussy, C.J.; Cluzel, M.; Ploy, M.C.; Kitzis, M.D.; Morel, C.; Bryskier, A.; Courvalin, P., 1999:
In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study

Carrillo-Muñoz, A.J.; Quindós, G.; Tur, C.; Ruesga, M.T.; Miranda, Y.; del Valle, O.; Cossum, P.A.; Wallace, T.L., 1999:
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole

Guarro, J.; Aguilar, C.; Pujol, I., 1999:
In-vitro antifungal susceptibilities of Basidiobolus and Conidiobolus spp. strains

Lohezic, F.; Amoros, M.; Boustie, J.; Girre, L., 1999:
In-vitro antiherpetic activity of Erythroxylon laurifolium (Erythroxylaceae)

Soriano, F.; Fernández-Roblas, R.; Calvo, R.; García-Calvo, G.; Pardeiro, M.; Bryskier, A., 1998:
In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens

Fuchs, P.C.; Barry, A.L.; Brown, S.D., 1999:
In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests

Suzuki, T.; Ezure, T.; Ishida, M., 1999:
In-vitro antitumour activity of extracts from cyanobacteria

Frémaux, A.; Sissia, G.; Geslin, P., 1999:
In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae

Naito, S.; Nishimura, M.; Yoshitsugu, H., 1999:
In-vitro biotransformation of BOF-4272, a sulphoxide-containing drug, in rats, mice and cynomolgus monkeys: Sex and species differences

Welkos, S.; Friedlander, A.; Weeks, S.; Little, S.; Mendelson, I., 2002:
In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody

Pan, L.P.; De Vriendt, C.; Belpaire, F.M., 1998:
In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol

Bourin, P.; Ledain, A.F.; Beau, J.; Mille, D.; Levi, F., 2002:
In-vitro circadian rhythm of murine bone marrow progenitor production

Ramos, G.; Cuenca-Estrella, M.; Monzón, A.; Rodríguez-Tudela, J.L., 1999:
In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp

Eouani, C.; Piccerelle, P.; Prinderre, P.; Bourret, E.; Joachim, J., 2001:
In-vitro comparative study of buccal mucoadhesive performance of different polymeric films

Molla, A.H.ssain; Fakhru'l Razi, A.; Abd Aziz, S.; Hanafi, M.M.sa; Alam, M.Z.hangir, 2001:
In-vitro compatibility evaluation of fungal mixed culture for bioconversion of domestic wastewater sludge

Li, L.Y.; Rodríguez-Hornedo, Nír.; Heimbach, T.; Fleisher, D., 2003:
In-vitro crystallization of indinavir in the presence of ritonavir and as a function of pH

Balaban, B.; Urman, B.; Sertac, A.; Alatas, C.; Aksoy, S.; Mercan, R.; Nuhoglu, A., 1999:
In-vitro culture of spermatozoa induces motility and increases implantation and pregnancy rates after testicular sperm extraction and intracytoplasmic sperm injection

Mccormack, G.; O'donoghue, D.; Baird, A., 2001:
In-vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in-vivo therapeutic response in ulcerative colitis

Yaïch, M.; Popon, M.; Médard, Y.; Aigrain, E.J., 1998:
In-vitro cytochrome P450 dependent metabolism of oxybutynin to N-deethyloxybutynin in humans

Maswadeh, H.; Demetzos, C.; Dimas, K.; Loukas, Y.L.; Georgopoulos, A.; Mavromoustakos, T.; Papaioannou, G.T., 2002:
In-vitro cytotoxic/cytostatic activity of anionic liposomes containing vinblastine against leukaemic human cell lines

Williams, T.M.; Rawlins, B.G.; Smith, B.; Breward, N., 1998:
In-vitro determination of arsenic bioavailability in contaminated soil and mineral beneficiation waste from Ron Phibun, Southern Thailand: A basis for improved human risk assessment

Liu, H.; Zhang, J.; Krey, L.C.; Grifo, J.A., 2000:
In-vitro development of mouse zygotes following reconstruction by sequential transfer of germinal vesicles and haploid pronuclei

Tesarik, J.; Mendoza, C.; Anniballo, R.; Greco, E., 2000:
In-vitro differentiation of germ cells from frozen testicular biopsy specimens

Obi, C.L.; Makandiramba, B.; Tswana, S.A.; Robertson, V.; Moyo, S.R.; Nziramasanga, P., 1999:
In-vitro disk diffusion sensitivity of meropenem against bacterial pathogens in Harare

Pourtau, J.; Soria, C.; Paysant, J.; Vannier, J.P.; Vasse, M., 1998:
In-vitro effect of oncostatin M on the release by endothelial cells of von Willebrand factor, tissue-type plasminogen activator and plasminogen activator inhibitor-1

Tesarik, J.; Martinez, F.; Rienzi, L.; Iacobelli, M.; Ubaldi, F.; Mendoza, C.; Greco, E., 2002:
In-vitro effects of FSH and testosterone withdrawal on caspase activation and DNA fragmentation in different cell types of human seminiferous epithelium

Oie, S.; Sawa, A.; Kamiya, A.; Mizuno, H., 1999:
In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa

Yule, F.S.B.; Watson, J.; Smith, K.D., 1999:
In-vitro effects of alpha1-acid glycoprotein on collagen fibril formation in rheumatoid arthritis

Behzadiyan Nejad, Q.; Souri, E.; Owlia, P., 1998:
In-vitro effects of sub-inhibitory concentrations of gentamicin on Pseudomonas aeruginosa alginate production

Bharathi, M.Jayahar.; Ramakrishnan, R.; Vasu, S.; Meenakshi, R.; Palaniappan, R., 2002:
In-vitro efficacy of antibacterials against bacterial isolates from corneal ulcers

Bredenberg, S.; Nystrom, C., 2003:
In-vitro evaluation of bioadhesion in particulate systems and possible improvement using interactive mixtures

Umezu, M.; Horikiri, Y.; Iwasaki, K.; Fujimoto, T., 2000:
In-vitro evaluation of coronary stents

Krishna, R.; Mayer, L.D., 1999:
In-vitro evaluation of doxorubicin cytotoxicity and cellular uptake in the presence and absence of multidrug resistance modulators

Taylor, K.M.G.; Pancholi, K.; Wong, D.Y.T., 1999:
In-vitro evaluation of dry powder inhaler formulations of micronized and milled nedocromil sodium

Coudron, P.E.; Stratton, C.W., 1998:
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori

Janssens, R.M.; Lambalk, C.B.; Vermeiden, J.P.; Schats, R.; Schoemaker, J., 2000:
In-vitro fertilization in a spontaneous cycle: easy, cheap and realistic

Shulman, A.; Feldman, B.; Madgar, I.; Levron, J.; Mashiach, S.; Dor, J., 1999:
In-vitro fertilization treatment for severe male factor: the fertilization potential of immotile spermatozoa obtained by testicular extraction

Hestin, D.; Gregoire, M.J.; Mayeux, D.; Mertes, P.M.; Lakosmky, D.; Kessler, M., 1998:
In-vitro growth patterns of bone marrow erythroid progenitors from patiens with post-renal transplant erythrocytosis

Balan, G.; Timmins, P.; Greene, D.S.; Marathe, P.H., 2000:
In-vitro in-vivo correlation models for glibenclamide after administration of metformin/glibenclamide tablets to healthy human volunteers

A.B.ng Wu; Hui Wen Cheng; Shu, J.C.en; Hsein Kun Lu; Chin Wen Lin; Chau Yang Chen, 2000:
In-vitro interaction of retinoic acid with telopeptide-poor collagen

Barchiesi, F.; Gallo, D.; Caselli, F.; Di Francesco, L.F.; Arzeni, D.; Giacometti, A.; Scalise, G., 1999:
In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans

Mikkelsen, A.L.; Smith, S.D.; Lindenberg, S., 1999:
In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming

Tesarik, J.; Mendoza, C.; Greco, E., 2000:
In-vitro maturation of immature human male germ cells

Cremades, N.; Bernabeu, R.; Barros, A.; Sousa, M., 1999:
In-vitro maturation of round spermatids using co-culture on Vero cells

De Vos, A.; Van de Velde, H.; Joris, H.; Van Steirteghem, A., 1999:
In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injection

Tang, C.; Shou, M.; Rushmore, T.H.; Mei, Q.; Sandhu, P.; Woolf, E.J.; Rose, M.J.; Gelmann, A.; Greenberg, H.E.; D.L.peleire, I.; Van Hecken, A.; D.S.hepper, P.J.; Ebel, D.L.; Schwartz, J.I.; Rodrigues, A.D., 2001:
In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics

Ahmad, M.; Ahmadi, M.; Nicholls, P.J.; Smith, H.J.hn, 2000:
In-vitro metabolism of retinoic acid by different tissues from male rats

Wu, W-Nan.; McKown, L.A.; Melton, J.L.; Reitz, A.B., 2003:
In-vitro metabolism of the new anxiolytic agent, RWJ-50172, in rat hepatic S9 fraction and microbial transformation in fungi, Cunninghamella sp

Agu, R.U.henna; Jorissen, M.; Willems, T.; Augustijns, P.; Kinget, R.; Verbeke, N., 2001:
In-vitro nasal drug delivery studies: Comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies

Gilling-Smith, C.; Mason, H.; Willis, D.; Franks, S.; Beard, R.W., 2000:
In-vitro ovarian steroidogenesis in women with pelvic congestion

Schlepckow, P.; Sigg, A., 2001:
In-vitro reconstruction of massive rotator cuff ruptures with triceps tendon or coracoacromial ligament

Trabelsi, E.B.hri; Bouzid, S.; Bouzid, M.; Elloumi, N.; Belfeleh, Z.; Benabdallah, A.; Ghezel, R., 2003:
In-vitro regeneration of olive tree by somatic embryogenesis

Watnasirichaikul, S.; Rades, T.; Tucker, I.G.; Davies, N.M., 2002:
In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion

Funke, A.P.ter; Guenther, C.; Mueller, R.H.lmut; Lipp, R., 2002:
In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS

Price, R.R.; Gaber, B.P.; Lvov, Y., 2001:
In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral

Kulkarni, A.R.; Soppimath, K.S.; Aminabhavi, T.M.; Rudzinski, W.E., 2001:
In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads

Soderberg, L.; Dyhre, H.; Roth, B.; Bjorkman, S., 2002:
In-vitro release of bupivacaine from injectable lipid formulations investigated by a single drop technique: Relation to duration of action in-vivo

Parsaee, S.; Sarbolouki, M.N.; Parnianpour, M., 2002:
In-vitro release of diclofenac diethylammonium from lipid-based formulations

Dorta, M.J.sus; Oliva, A.; Munguia, O.; Llabres, M.; Farina, J.B., 2002:
In-vitro release of fluoropyrimidines from PLGA film implants

Defontaine, A.; Bouchara, J.P.; Declerk, P.; Planchenault, C.; Chabasse, D.; Hallet, J.N., 1999:
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata

Hernandez-Guerrero, C.; Monzon-Bordonaba, F.; Jimenez-Zamudio, L.; Ahued-Ahued, R.; Arechavaleta-Velasco, F.; Strauss, J.F.; Vadillo-Ortega, F., 2003:
In-vitro secretion of proinflammatory cytokines by human amniochorion carrying hyper-responsive gene polymorphisms of tumour necrosis factor-alpha and interleukin-1beta

Park, S.Y.ung; Murthy, H.N.; Paek, K.Y.eup, 2000:
In-vitro seed germination of Calanthe sieboldii, an endangered orchid species

Tesarik, J.; Balaban, B.; Isiklar, A.; Alatas, C.; Urman, B.; Aksoy, S.; Mendoza, C.; Greco, E., 2000:
In-vitro spermatogenesis resumption in men with maturation arrest: relationship with in-vivo blocking stage and serum FSH

Sargazi, M.; Roberts, N.B.; Shenkin, A., 2001:
In-vitro studies of aluminium-induced toxicity on kidney proximal tubular cells

Munir, M.; Iqbal, S.; Baloch, J.U.D.n; Ahmad, M.; Quraishi, A., 1999:
In-vitro studies on four exotic cultivars of strawberry

Ni'matuzahroh; Gilewicz, M.; Guiliano, M.; Bertrand, J.C., 1999:
In-vitro study of interaction between photooxidation and biodegradation of 2-methylphenanthrene by Sphingomonas sp. 2MPII

Malpica, M.I.; Rodriguez, A.B.; Saez, M.C.; Garcia, J.J.; Barriga, C.; Ortega, E., 2002:
In-vitro study of the effect of adrenaline on the functional capacity of human neutrophils: Role during exercise

Y.H.i; W.J.min; Huang Weiyi, 1998:
In-vitro study on the activities of quinolones and other antibiotics against mycoplasmas

Betriu, C.; Sánchez, A.; Gómez, M.; Palau, M.L.; Picazo, J.J., 1999:
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents

Blondeau, J.M.; Yaschuk, Y.; Suter, M.; Vaughan, D.; Canadian Antimicrobial Study Group, 1999:
In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: A Canadian multicentre study

Long-Feng; Zhang-Yong-Xin; Li-Ming; Zhang-Qiang-Qiang; Wang-Jia-Jun, 2002:
In-vitro susceptibility of 248 isolates of Candida sp. and Cryptococcus neoformans to four antifungal agents

Dannaoui, E.; Persat, F.; Monier, M.F.; Borel, E.; Piens, M.A.; Picot, S., 1999:
In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole

Ungheri, D.; Albini, E.; Belluco, G., 2002:
In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol

Meyer, J.M.; Ryu, S.; Pendland, S.L.; Kanyok, T.P.; Danziger, L.H., 1999:
In-vitro synergy of paromomycin with metronidazole alone or metronidazole plus hydroxymetronidazole against Helicobacter pylori

Dannhardt, G.; Ulbrich, H., 2001:
In-vitro test system for the evaluation of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors based on a single HPLC run with UV detection using bovine aortic coronary endothelial cells (BAECs)

Back, N.K.; van Wijk, A.; Remmerswaal, D.; van Monfort, M.; Nijhuis, M.; Schuurman, R.; Boucher, C.A., 2000:
In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors

Patil, R.M.; Karpe, A.G.; Gujar, M.B., 2000:
In-vitro transfer of drug resistance in Escherichia coli

Leertouwer, T.C.; Gussenhoven, E.J.; van Jaarsveld, B.C.; van Overhagen, H.; Bom, N.; Man in 't Veld, A.J., 1999:
In-vitro validation, with histology, of intravascular ultrasound in renal arteries

Loetzbeyer, F.; Gruebl, A.; Bauer, C.P., 2002:
In-vitro-Allergiescreening mit Pharmacia SX1- und fx5-Test im Vergleich zur Einzelallergenbestimmung durch den Pharmacia CAP-RAST und Vergleich des Pharmacia CAP-RAST mit dem DPC-PolyCheck

Hoelzl, F.; Pfannschmidt, O.; Manegold, E.; Rohrmann, D.; Jakse, G.; Brauers, A., 2000:
In-vitro-Analytik und tierexperimentelle Untersuchung oberflaechenmodifizierter biodegradierbarer Polylactidureterstents

Zetzsche, T.; Meisenzahl, E., M.; Preuss, U., W.; Holder, J., J.; Kathmann, N.; Leinsinger, G.; Hahn, K.; Hegerl, U.; Moeller, H.-Juergen, 2001:
In-vivo analysis of the human planum temporale (PT): Does the definition of PT borders influence the results with regard to cerebral asymmetry and correlation with handedness?

Kitazawa, T.; Hosoya, K.I.hi; Takahashi, T.; Sugiyama, Y.; Terasaki, T., 2000:
In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for Oestrone-3-sulphate across the blood-cerebrospinal fluid barrier

Higashikawa, F.; Murakami, T.; Kaneda, T.; Takano, M., 1999:
In-vivo and in-vitro metabolic clearance of midazolam, a cytochrome P450 3A substrate, by the liver under normal and increased enzyme activity in rats

Hague, S.; MacKenzie, I.Z.; Bicknell, R.; Rees, M.C.P., 2002:
In-vivo angiogenesis and progestogens

Sánchez, C.; Arnt, J., 2000:
In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics

Lee, S.H.; Szinai, I.; Carpenter, K.; Katsarava, R.; Jokhadze, G.; Chu, C-Chang.; Huang, Y.; Verbeken, E.; Bramwell, O.; D.S.heerder, I.; Hong, M.K., 2002:
In-vivo biocompatibility evaluation of stents coated with a new biodegradable elastomeric and functional polymer

Shinya, E.; Dervillez, X.; Edwards Levy, F.; Duret, V.; Brisson, E.; Ylisastigui, L.; Levy, M.C.; Cohen, J.H.M.; Klatzmann, D., 1999:
In-vivo delivery of therapeutic proteins by genetically-modified cells: Comparison of organoids and human serum albumin alginate-coated beads

Walker, Z.; Costa, D.C.; Ince, P.; Mckeith, I.G.; Katona, C.L.E., 1999:
In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies

Mangili, P.; Fiorino, C.; Rosso, A.; Cattaneo, G.M.uro; Parisi, R.; Villa, E.; Calandrino, R., 1999:
In-vivo dosimetry by diode semiconductors in combination with portal films during TBI: Reporting a 5-year clinical experience

Blanco, M.D.; Garcia, O.; Gomez, C.; Sastre, R.L.; Teijon, J.M., 2000:
In-vivo drug delivery of 5-fluorouracil using poly(2-hydroxyethyl methacrylate-co-acrylamide) hydrogels

Sofowora, G.; Dishy, V.; Xie, H.G.; Imamura, H.; Nishimi, Y.; Morales, C.R.; Morrow, J.D.; Kim, R.B.; Stein, C.M.; Wood, A.J., 2001:
In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism

Saxena, A.K.mar; Singh, G., 2001:
In-vivo evaluation of chromosome aberrations in two differrent test-system following antenatal exposure of cyclophosphamide to the developing rat foetus: A day and dose dependent mutagenicity

Mukai, T.; Arano, Y.; Nishida, K.; Sasaki, H.; Saji, H.; Nakamura, J., 1999 :
In-vivo evaluation of indium-111-diethylenetriaminepentaacetic acid-labelling for determining the sites and rates of protein catabolism in mice

Zion, B.; Shklyar, A.; Karplus, I., 2000:
In-vivo fish sorting by computer vision

Davis, J.H.; Mittleman, R.E., 1998:
In-vivo glutaraldehyde fixation of the brain stem and spinal cord after inadvertent intrathecal injection

Pocernich, C.B.; L.F.ntaine, M.; Butterfield, D.A., 2000:
In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain

Wen, Yue Jin; Lim, Seah, H., 1998:
In-vivo immune responses to idiotypic VH complementarity-determining region 3 peptide vaccination in B-cell non-Hodgkin's lymphoma

Chladek, J.; Zimova, G.; Beranek, M.; Martinkova, J., 2000:
In-vivo indices of CYP2D6 activity: Comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasma

Rostami-Hodjegan, A.; Kroemer, H.K.; Tucker, G.T., 1999:
In-vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activity

Khong, T.K.; McIntyre, D.J.; Sagnella, G.A.; Markandu, N.D.; Miller, M.A.; Baker, E.H.; Griffiths, J.R.; MacGregor, G.A., 2001:
In-vivo intracellular pH at rest and during exercise in patients with essential hypertension

Takedomi, S.; Matsuo, H.; Yamano, K.; Ohtani, H.; Sawada, Y., 2001:
In-vivo kinetics of the interaction between midazolam and erythromycin in rats, taking account of metabolic intermediate complex formation

Cagnin, A.; Brooks, D.J.; Kennedy, A.M.; Gunn, R.N.; Myers, R.; Turkheimer, F.E.; Jones, T.; Banati, R.B., 2001 :
In-vivo measurement of activated microglia in dementia

Jauniaux, E.; Watson, A.; Ozturk, O.; Quick, D.; Burton, G., 1999:
In-vivo measurement of intrauterine gases and acid-base values early in human pregnancy

Genicot, J.L.; Pommé, S.; Alzetta, J.P., 1999:
In-vivo measurement of low energy photon emitters: room-temperature semiconductor diodes vs. large scintillators and germanium crystals

Herholz, K.; Bauer, B.; Wienhard, K.; Kracht, L.; Mielke, R.; Lenz, O.; Strotmann, T.; Heiss, W.D., 2000:
In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: Comparison with blood flow and glucose metabolism

Doriot, P.A.; Dorsaz, P.A.; Dorsaz, L.; D.B.nedetti, E.; Chatelain, P.; Delafontaine, P., 2000:
In-vivo measurements of wall shear stress in human coronary arteries

Izzo, A.A.; Addeo, D.; Amato, M.; Borrelli, F.; Capasso, R.; D.C.rlo, G.; Nocerino, E.; Mascolo, N.; Pinto, L.; Capasso, F., 2000:
In-vivo modulation of gastrointestinal motility by cannabinoid drugs

Cheung, A.P.; Pride, S.M.; Yuen, B.Ho.; Sy, L., 2002:
In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome

Sohn, R.L.; Murray, M.T.; Schwarz, K.; Nyitray, J.; Purray, P.; Franko, A.P.; Palmer, K.C.; Diebel, L.N.; Dulchavsky, S.A., 2001:
In-vivo particle mediated delivery of mRNA to mammalian tissues: Ballistic and biologic effects

Lin, Y.S.; Lockwood, G.F.; Graham, M.A.; Brian, W.R.; Loi, C.M.; Dobrinska, M.R.; Shen, D.D.; Watkins, P.B.; Wilkinson, G.R.; Kharasch, E.D.; Thummel, K.E., 2001:
In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration

Block, W.; Träber, F.; Flacke, S.; Jessen, F.; Pohl, C.; Schild, H., 2002:
In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration

Naito, S.; Nishimura, M.; Nogawa, H.; Yoshitsugu, H.; Tamao, Y.; Asano, S.; Nomura, Y., 2000:
In-vivo sex differences in disposition and metabolism of sulphoxide-containing drug BOF-4272 in rats

Chiladakis, J.A.; Davlouros, P.; Agelopoulos, G.; Manolis, A.S., 2001:
In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators

Nishizawa, K.; Saze, T.; Etho, M.; Murabayashi, K.; Iwai, S., 2001:
In-vivo thyroid 125I monitoring method using imaging plate

Filippi, Massimo, 2001:
In-vivo tissue characterization of multiple sclerosis and other white matter diseases using magnetic resonance based techniques

Pedraza, R.O.; Diaz-Ricci, J.C., 2002:
In-well cell lysis technique reveals two new megaplasmids of 103.0 and 212.6 MDa in the multiple plasmid-containing strain V517 of Escherichia coli

Riccio, M.L.; Pallecchi, L.; Fontana, R.; Rossolini, G.M., 2001:
In70 of plasmid pAX22, a bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette

Perler, Francine, B., 2002:
InBase: The Intein Database

Bandini, M.; Cozzi, P.Giorgio.; Melchiorre, P.; Umani-Ronchi, A., 2002:
InBr3-catalyzed Friedel-Crafts addition of indoles to chiral aromatic epoxides: a facile route to enantiopure indolyl derivatives

Yadav, J.S.; Reddy, B.V.S.; Krishna, A.D.; Swamy, T., 2003:
InBr3-catalyzed sulfonation of indoles: A facile synthesis of 3-sulfonyl indoles

Sengupta, S.; Mondal, S., 2000:
InCl3 catalyzed reactions of ethyl diazoacetate with aldimines: A highly diastereoselective synthesis of cis-aziridine carboxylates

Zhang, J.; Li, C.J.n, 2002:
InCl3-catalyzed domino reaction of aromatic amines with cyclic enol ethers in water: A highly efficient synthesis of new 1,2,3,4-tetrahydroquinoline derivatives

Yadav, J.S.; Reddy, B.V.S.; Rao, R.S.inivasa; Kumar, S.K.ran; Kunwar, A.C., 2002:
InCl3-catalyzed hetero-Diels-Alder reaction: An expeditious synthesis of pyranoquinolines

Li, Z.; Zhang, J.; Li, C.J.n, 2003:
InCl3-catalyzed reaction of aromatic amines with cyclic hemiacetals in water: Facile synthesis of 1,2,3,4-tetrahydroquinoline derivatives

Yadav, J.S.; Reddy, B.V.S.; Abraham, S.; Sabitha, G., 2002:
InCl3-catalyzed regioselective opening of aziridines with heteroaromatics

Yadav, J.S.; Reddy, B.V.S.; Raman, J.V.; Niranjan, N.; Kumar, S.K.ran; Kunwar, A.C., 2002:
InCl3-catalyzed stereoselective synthesis of C-glycosyl heteroaromatics

Loh, T-Peng.; Chen, S-Ling., 2002:
InCl(3)-catalyzed three-component asymmetric Mannich-type reaction in methanol

Beverly, A.; Bailey-Griffin, J.R.; Schwebke, J.R., 2000:
InTray GC medium versus modified Thayer-Martin agar plates for diagnosis of gonorrhea from endocervical specimens

Yabumoto, Y.; Uyeno, T., 2000:
Inabaperca taniurai, a new genus and species of miocene percoid fish from Tottori Prefecture, Japan

Still, M.; Lindström, E.; Ekstrand, A.Jonas.; Mild, K.Hansson.; Mattsson, M-Olof.; Lundgren, E., 2002:
Inability of 50 Hz magnetic fields to regulate PKC- and Ca(2+)-dependent gene expression in Jurkat cells

Sarda, L.; Crémieux, A-Claude.; Lebellec, Y.; Meulemans, A.; Lebtahi, R.; Hayem, G.; Génin, Rémi.; Delahaye, N.; Huten, D.; L.G.ludec, D., 2003:
Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases

Wilson, R.S.; Franklin, C.E., 2000:
Inability of adult Limnodynastes peronii (Amphibia: Anura) to thermally acclimate locomotor performance

Van Campenhout, N.; D.H.es, P.; Meert, T.F., 1999:
Inability of antipsychotics to antagonize the cueing properties of cocaine in rats

Akimoto, S.; Furuya, Y.; Akakura, K.; Shimazaki, J.; Ito, H., 1999:
Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: Comparison with the extent of disease (EOD) grade

Goenka, S.; Rao, C.M.han, 2000:
Inability of chaperones to fold mutant zeta-crystallin, an aggregation-prone eye lens protein

Yoshikawa, M.; Tomita, Y.; Uchida, T.; Zhang, Q.W.; Nomoto, K., 2000:
Inability of cyclophosphamide-induced tolerance to permit engraftment of pluripotent stem cells contained in a moderate number of syngeneic bone marrow cells

Matatov, R.; Goldhar, J.; Skutelsky, E.; Sechter, I.; Perry, R.; Podschun, R.; Sahly, H.; Thankavel, K.; Abraham, S.N.; Ofek, I., 1999:
Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface

Hu, C.; Salgame, P., 1999:
Inability of interleukin-12 to modulate T-helper 0 effectors to T-helper 1 effectors: A possible distinct subset of T cells

Abe, M.; Akbar, S.M.F.zle; Horiike, N.; Onji, M., 2003:
Inability of liver dendritic cells from mouse with experimental hepatitis to process and present specific antigens

Bonaparte, M.I.; Barker, E., 2003:
Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes

Stannard, A.K.; Khan, S.; Graham, A.; Owen, J.S.; Allen, S.P., 2001:
Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells

Zerbe, M.J.; Bristow, R.; Grumbine, F.C.; Montz, F.J., 2000:
Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer

Patel, V.B.; Richardson, P.J.; Preedy, V.R., 2000:
Inability of propranolol to prevent alcohol-induced reductions in cardiac protein synthesis in vivo

Reber, G.; Blanchard, J.; Bounameaux, H.; Hoffmeyer, P.; Miron, M.J.; Leyvraz, P.F.; de Moerloose, P., 2000:
Inability of serial fibrin monomer measurements to predict or exclude deep venous thrombosis in asymptomatic patients undergoing total knee arthroplasty

Banes, A.K.L.; Loberg, R.D.; Brosius, F.C.IIi; Watts, S.W., 2001:
Inability of serotonin to activate the c-Jun N-terminal kinase and p38 kinase pathways in rat aortic vascular smooth muscle cells

Adams, J.S.; Kantorovich, V., 1999:
Inability of short-term, low-dose hydroxychloroquine to resolve vitamin D-mediated hypercalcemia in patients with B-cell lymphoma

Dhume, A.S.; Agrawal, D.K., 2003:
Inability of vascular smooth muscle cells to proceed beyond S phase of cell cycle, and increased apoptosis in symptomatic carotid artery disease

Zimmermann, B.; Holzgreve, W.; Zhong, X.Yan.; Hahn, S., 2002:
Inability to clonally expand fetal progenitors from maternal blood

Kim, J.S.; Choi, S.; Kwon, S.U.; Seo, Y.S., 2002:
Inability to control anger or aggression after stroke

Harwix, S.; Günzl, H.J.; Blaschke, V.; Zachmann, K.; Neumann, C., 2001:
Inability to culture the dominant T-cell clone from the skin of primary cutaneous T-cell lymphoma as proven by TCR gamma-chain gene sequencing

Rossi, D.J.; Londesborough, A.; Korsisaari, N.; Pihlak, A.; Lehtonen, E.; Henkemeyer, M.; Mäkelä, T.P., 2001:
Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1

Havlin, K.A.; Ramirez, M.J.; Legler, C.M.; Harris, L.N.; Matulonis, U.A.; Hohneker, J.A.; Hayes, D.F.; Winer, E.P., 1999:
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer

Singleton, R.; Etchart, N.; Hou, S.; Hyland, L., 2003:
Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses

Rosenberg, S.A.; Yang, J.C.; Sherry, R.M.; Hwu, P.; Topalian, S.L.; Schwartzentruber, D.J.; Restifo, N.P.; Haworth, L.R.; Seipp, C.A.; Freezer, L.J.; Morton, K.E.; Mavroukakis, S.A.; White, D.E., 2003:
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen

Pachori, A.S.; Wang, H.; Gelband, C.H.; Ferrario, C.M.; Katovich, M.J.; Raizada, M.K., 2000:
Inability to induce hypertension in normotensive rat expressing AT(1) receptor antisense

Vermeij, C.G.; Smit, F.W.; Elsman, B.H., 2001:
Inability to monitor polyurethane haemodialysis vascular access graft by Doppler ultrasound

Twedt, D.J.; Linz, G.M.; Bleier, W.J., 2001:
Inability to predict geographic origin of Yellow-headed Blackbirds, Xanthocephalus xanthocephalus, during migration

Vieth, R.; Rao, D.Sudhaker., 2003:
Inaccuracies in relating 25-hydroxyvitamin D to ischemic heart disease

Bolotin, H.H., 2001:
Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral densitometry may flaw osteopenic/osteoporotic interpretations and mislead assessment of antiresorptive therapy effectiveness

Bolotin, H.H.; Sievänen, H.; Grashuis, J.L.; Kuiper, J.W.; Järvinen, T.L., 2001:
Inaccuracies inherent in patient-specific dual-energy X-ray absorptiometry bone mineral density measurements: comprehensive phantom-based evaluation

Letic, Milorad, 2003:
Inaccuracy in cervical dilatation assessment and the progress of labour monitoring

Coen, V.L.M.A.; Marijnissen, J.P.A.; Ligthart, J.M.R.; D.P.n, C.; Drenth, J.; Den Boer, A.; Van Der Giessen, W.J.; Serruys, P.W.; Levendag, P.C., 2002:
Inaccuracy in manual multisegmental irradiation in coronary arteries

Schwab, L.T.; Roberts, J.R.; Reigart, J.Routt., 2003:
Inaccuracy in parental reporting of the age of their home for lead-screening purposes

Fitzcharles, M-A.; Boulos, P., 2003:
Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals

Donovan, E.F.; Tyson, J.E.; Ehrenkranz, R.A.; Verter, J.; Wright, L.L.; Korones, S.B.; Bauer, C.R.; Shankaran, S.; Stoll, B.J.; Fanaroff, A.A.; Oh, W.; Lemons, J.A.; Stevenson, D.K.; Papile, L.A.n, 1999:
Inaccuracy of Ballard scores before 28 weeks' gestation

Wägner, A.M.; Sánchez-Quesada, J.L.; Pérez, A.; Rigla, M.; Cortés, M.; Blanco-Vaca, F.; Ordóñez-Llanos, J., 2000:
Inaccuracy of calculated LDL-cholesterol in type 2 diabetes: consequences for patient risk classification and therapeutic decisions

Zarif, L.; Covic, A.; Iyengar, S.; Sehgal, A.R.; Sedor, J.R.; Schelling, J.R., 2000:
Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis

Lofaso, F.; Fodil, R.; Lorino, H.; Leroux, K.; Quintel, A.; Leroy, A.; Harf, A., 2000:
Inaccuracy of tidal volume delivered by home mechanical ventilators

Oelrichs, R.B.; Dyer, W.B.; Downie, J.C.; Harvey, K.; Sullivan, J.S.; Workman, C., 1999:
Inaccurate HIV-1 viral load quantification by three major commercially available methods

Johnson, D.W., 1999:
Inaccurate measurement of free carnitine by the electrospray tandem mass spectrometry screening method for blood spots

Tada, M.; Furuuchi, K.; Kaneda, M.; Matsumoto, J.; Takahashi, M.; Hirai, A.; Mitsumoto, Y.; Iggo, R.D.; Moriuchi, T., 2001:
Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants

Kuznetsova, I.M.; Turoverov, K.K.; Uversky, V.N., 1999:
Inactivated actin, an aggregate comprised of partially-folded monomers, has an overall native-like packing density

Landry, P.; Tremblay, S.; Darioli, R.; Genton, B., 2000:
Inactivated hepatitis A vaccine booster given gtoreq24 months after the primary dose

Tsang, S.W.C.; Sung, J.J.Y., 1999:
Inactivated hepatitis A vaccine in Chinese patients with chronic hepatitis B infection

Herland Berstad, A.K.trine; Andersen, S.R.ne; Dalseg, R.; Dromtorp, S.; Holst, J.; Namork, E.; Wedege, E.; Haneberg, B., 2000:
Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

Sieradzki, K.; Pinho, M.G.; Tomasz, A., 1999:
Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus

Hovi, Tapani, 2001:
Inactivated poliovirus vaccine and the final stages of poliovirus eradication

Fournier-Caruana, J.; Poirier, B.; Haond, Gève.; Jallet, C.; Fuchs, F.; Tordo, Nël.; Perrin, P., 2003:
Inactivated rabies vaccine control and release: use of an ELISA method

Tsushima, R.G.; Borges, A.; Backx, P.H., 1999:
Inactivated state dependence of sodium channel modulation by beta-scorpion toxin

Kirubaharan, J.J.hn; Albert, A., 2002:
Inactivated vaccines against Newcastle disease: 1. Preparation and standardisation

Kirubaharan, J.J.hn; Albert, A., 2002:
Inactivated vaccines against newcastle disease 3. Cell mediated immune response

Tapanainen, J.S.; Vaskivuo, T.; Aittomaki, K.; Huhtaniemi, I.T., 1998:
Inactivating FSH receptor mutations and gonadal dysfunction

Marcotti, W.; Russo, G.; Prigioni, I., 1999:
Inactivating and non-activating delayed rectifier K+ currents in hair cells of frog crista ampullaris

Karaplis, A.C.; He, B.; Nguyen, M.T.; Young, I.D.; Semeraro, D.; Ozawa, H.; Amizuka, N., 1998:
Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia

Caterina, J.J.; Yamada, S.; Caterina, N.C.; Longenecker, G.; Holmbäck, K.; Shi, J.; Yermovsky, A.E.; Engler, J.A.; Birkedal-Hansen, H., 2000:
Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation

Moreno, Jé.C.; Bikker, H.; Kempers, M.J.E.; van Trotsenburg, A.S.Paul.; Baas, F.; de Vijlder, J.J.M.; Vulsma, T.; Ris-Stalpers, C., 2002:
Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism

Shin, M.S.n; Kim, H.S.g; Kang, C.S.k; Park, W.S.ng; Kim, S.Y.ung; Lee, S.N.e; Lee, J.H.un; Park, J.Y.ung; Jang, J.J.ne; Kim, C.W.o; Kim, S.H.; Lee, J.Y.ung; Yoo, N.J.n; Lee, S.H.ung, 2002:
Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas

Park, W.S.ng; Lee, J.H.un; Shin, M.S.n; Park, J.Y.ung; Kim, H.S.g; Kim, Y.S.l; Park, C.H.un; Lee, S.K.u; Lee, S.H.ung; Lee, S.N.e; Kim, H.; Yoo, N.J.n; Lee, J.Y.ung, 2001:
Inactivating mutations of KILLER/DR5 gene in gastric cancers

Kim, H.S.g; Lee, J.W.o; Soung, Y.H.a; Park, W.S.ng; Kim, S.Y.ung; Lee, J.H.un; Park, J.Y.ung; Cho, Y.G.; Kim, C.J.e; Jeong, S.W.an; Nam, S.W.o; Kim, S.H.; Lee, J.Y.ung; Yoo, N.J.n; Lee, S.H.ung, 2003:
Inactivating mutations of caspase-8 gene in colorectal carcinomas

Toledo, S.P., 1999 :
Inactivating mutations of the LH receptor gene: more than two different phenotypes

Mariatos, G.; Bothos, J.; Zacharatos, P.; Summers, M.K.; Scolnick, D.M.; Kittas, C.; Halazonetis, T.D.; Gorgoulis, V.G., 2003:
Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer

Riochet, D.F.; Mohammad-Panah, R.; Hebert, S.C.; MacGregor, G.G.; Baró, I.; Guihard, G.; Escande, D., 2001:
Inactivating properties of recombinant ROMK2 channels expressed in mammalian cells

Johnston, A.; Macgregor, A.; Borovec, S.; Hattarki, M.; Stuckly, K.; Anderson, D.; Goss, N.H.; Oates, A.; Uren, E., 2000:
Inactivation and clearance of viruses during the manufacture of high purity factor IX

Shi, Y.; Luo, W.; Tian, W.X.; Zhang, T.; Zhou, H.M.ng, 1998:
Inactivation and conformational changes of fatty acid synthase from chicken liver during unfolding by sodium dodecyl sulfate

Zheng, Y.B.n; Meng, F.G.o; Chen, B.Y.; Wang, X.C.eng, 2002:
Inactivation and conformational changes of lactate dehydrogenase from porcine heart in sodium dodecyl sulfate solutions

Yang, Y.; Zhang, X.S.; Zhou, H.M., 1998:
Inactivation and conformational changes of yeast alcohol dehydrogenase in trifluoroethanol solutions

Liu, L.; Xu-Welliver, M.; Kanugula, S.; Pegg, A.E., 2002:
Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide

Meier, R.; Thelen, M.; Hemmings, B.A., 1998:
Inactivation and dephosphorylation of protein kinase Balpha (PKBalpha) promoted by hyperosmotic stress

Lozinski, T.; Wierzchowski, K.L., 2003 :
Inactivation and destruction by KMnO4 of Escherichia coli RNA polymerase open transcription complex: Recommendations for footprinting experiments

Choi, S.; Silverman, R.B., 2002:
Inactivation and inhibition of gamma-aminobutyric acid aminotransferase by conformationally restricted vigabatrin analogues

Damar, S.; Bozoglu, F.; Hizal, M.; Bayindirli, A., 2002:
Inactivation and injury of Escherichia coli O157:H7 and Staphylococcus aureus by pulsed electric fields

Jordan, S.; Pascual, C.B.acey, E.M.ckey, B., 2001:
Inactivation and injury of pressure-resistant strains of Escherichia coli O157 and Listeria monocytogenes in fruit juices

Yan, H.; Harding, J.J., 1999:
Inactivation and loss of antigenicity of esterase by sugars and a steroid

Jerng, H.H.; Gilly, W.F., 2002:
Inactivation and pharmacological properties of sqKv1A homotetramers in Xenopus oocytes cannot account for behavior of the squid "delayed rectifier" K(+) conductance

Machado, M.F.; Saraiva, J., 2002:
Inactivation and reactivation kinetics of horseradish peroxidase in phosphate buffer and buffer-dimethylformamide solutions

Raman, I.M.; Bean, B.P., 2001:
Inactivation and recovery of sodium currents in cerebellar Purkinje neurons: evidence for two mechanisms

Peng, J.; Tsai, W.; Chou, C., 2002:
Inactivation and removal of Bacillus cereus by sanitizer and detergent

Schwarz, S.; Greffrath, W.; Buesselberg, D.; Treede, R.D.tlef, 2000:
Inactivation and tachyphylaxis of heat-evoked inward currents in nociceptive primary sensory neurones of rats

Romero, J.M.; Carrizo, M.E.; Montich, G.; Curtino, J.A., 2001:
Inactivation and thermal stabilization of glycogenin by linked glycogen

Iwata, S.; Murakami, K.; Haneda, M.; Yoshino, M., 1999:
Inactivation by gallic acid of cytosolic aconitase extracted from rat liver

Klughammer, B.; Baier, M.; Dietz, K.J.sef, 1998:
Inactivation by gene disruption of 2-cysteine-peroxiredoxin in Synechocystis sp. PCC 6803 leads to increased stress sensitivity

Mofidi, A.A.; Baribeau, H.; Rochelle, P.A.; De-Leon, R.; Coffey, B.M.; Green, J.F., 2002:
Inactivation de Cryptosporidium parvum a l'aide de rayonnement UV polychromatique

Marksteiner, R.; Schurr, P.; Berjukow, S.; Margreiter, E.; Perez Reyes, E.; Hering, S., 2001:
Inactivation determinants in segment IIIS6 of Cav3.1

Otaki, M.; Okuda, A.; Tajima, K.; Iwasaki, T.; Kinoshita, S.; Ohgaki, S., 2003:
Inactivation differences of microorganisms by low pressure UV and pulsed xenon lamps

Nie Rong Guo; Yin Wen Jie; Yang Hong Yu; Chen Shu Liang; Chen Wei Jin; Guo Yan; Xie Xin; L.D.Q.; Liu Shu Ying, 2003:
Inactivation effect of incubation at low pH value on virus and influence of it on quality of human immunoglobulin

Judge, S.I.V.; Monteiro, M.J.; Yeh, J.Z.; Bever, C.T., 1999:
Inactivation gating and 4-AP sensitivity in human brain Kv1.4 potassium channel

Pedruzzi, I.; Rosenbusch, J.P.; Locher, K.P., 1998:
Inactivation in vitro of the Escherichia coli outer membrane protein FhuA by a phage T5-encoded lipoprotein

Erkmen, Osman, 2000:
Inactivation kinetics of Listeria monocytogenes in Turkish White cheese during the ripening period

Claeys, W.L.; Ludikhuyze, L.R.; van Loey, A.M.; Hendrickx, M.E., 2001:
Inactivation kinetics of alkaline phosphatase and lactoperoxidase, and denaturation kinetics of beta-lactoglobulin in raw milk under isothermal and dynamic temperature conditions

Kim, J.; Yousef, A., 2000:
Inactivation kinetics of foodborne spoilage and pathogenic bacteria by ozone

Borovec, S.; Broumis, C.; Adcock, W.; Fang, R.; Uren, E., 1999:
Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat

Zhou, Y.; Lau, F.W.; Nauli, S.; Yang, D.; Bowie, J.U., 2001:
Inactivation mechanism of the membrane protein diacylglycerol kinase in detergent solution

Dhar, S.; Squire, J.A.; Hande, M.P.; Wellinger, R.J.; Pandita, T.K., 2000:
Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability

Alper, R.H.; Nelson, D.L., 2000:
Inactivation of 5-HT1A receptors in hippocampal and cortical homogenates

Zervosen, A.; Valladares, M.H.; Devreese, B.; Prosperi-Meys, C.; Adolph, H.W.; Mercuri, P.S.; Vanhove, M.; Amicosante, G.; van Beeumen, J.; Frère, J.M.; Galleni, M., 2001:
Inactivation of Aeromonas hydrophila metallo-beta-lactamase by cephamycins and moxalactam

Khoo, S.Kean.; Kahnoski, K.; Sugimura, J.; Petillo, D.; Chen, J.; Shockley, K.; Ludlow, J.; Knapp, R.; Giraud, S.; Richard, Séphane.; Nordenskjöld, M.; Teh, B.Tean., 2003:
Inactivation of BHD in sporadic renal tumors

Xia, X-Ming.; Ding, J.P.; Lingle, C.J., 2003:
Inactivation of BK channels by the NH2 terminus of the beta2 auxiliary subunit: an essential role of a terminal peptide segment of three hydrophobic residues

Lingle, C.J.; Zeng, X.H.; Ding, J.P.; Xia, X.M., 2001:
Inactivation of BK channels mediated by the NH(2) terminus of the beta3b auxiliary subunit involves a two-step mechanism: possible separation of binding and blockade

Hilton, J.L.; Geisler, J.P.; Rathe, J.A.; Hattermann-Zogg, M.A.; DeYoung, B.; Buller, R.E., 2002:
Inactivation of BRCA1 and BRCA2 in ovarian cancer

Furukawa, S.; Saita, K.; Kato, T.; Shimoda, M.; Hayakawa, I., 2000:
Inactivation of Bacillus stearothermophilus and Bacillus coagulans spores as indicators of sterilization by reciprocal pressurization

Heinz, V.P.illips, S.; Zenker, M.K.orr, D., 1999:
Inactivation of Bacillus subtilis by high intensity pulsed electric fields under close to isothermal conditions

Driedger, A.; Staub, E.; Pinkernell, U.; Marinas, B.; Koster, W.; Von Gunten, U., 2001:
Inactivation of Bacillus subtilis spores and formation of bromate during ozonation

Raso, J.; Palop, A.; Pagan, R.; Condon, S., 1998:
Inactivation of Bacillus subtilis spores by combining ultrasonic waves under pressure and mild heat treatment

Warriner, K.; Rysstad, G.; Murden, A.; Rumsby, P.; Thomas, D.; Waites, W.M., 2000:
Inactivation of Bacillus subtilis spores on aluminum and polyethylene preformed cartons by UV-excimer laser irradiation

Warriner, K.; Rysstad, G.; Murden, A.; Rumsby, P.; Thomas, D.; Waites, W.M., 2000:
Inactivation of Bacillus subtilis spores on packaging surfaces by u.v. excimer laser irradiation

Larson, M.A.; Marinas, B.J., 2003:
Inactivation of Bacillus subtilis spores with ozone and monochloramine

Zhou, C.-Qin; Nakagaki, M.; Takizawa, K.; Tsuda, H.; Kajiura, Z.; Takei, R.; Iwashita, Y., 1999:
Inactivation of Bombyx mori nucleopolyhedrovirus (BmNPV) with calcium hydroxide solution

Mitchell, D.J.; Nikolic, D.; Jang, M.H.; van Breemen, R.B.; Hille, R.; Silverman, R.B., 2001:
Inactivation of C30A trimethylamine dehydrogenase by N-cyclopropyl-alpha-methylbenzylamine, 1-phenylcyclopropylamine, and phenylhydrazine

Campbell, W.D.; Lazoura, E.; Okada, N.; Okada, H., 2002:
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N

Toyota, M.; Ho, C.; Ohe-Toyota, M.; Baylin, S.B.; Issa, J.P., 1999:
Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors

Chou, H-Hua.; Hayakawa, T.; Diaz, S.; Krings, M.; Indriati, E.; Leakey, M.; Paabo, S.; Satta, Y.; Takahata, N.; Varki, A., 2002:
Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution

Bonomo, R.A.; Liu, J.; Chen, Y.; Ng, L.; Hujer, A.M.; Anderson, V.E., 2001:
Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization

Qi, H.; Li, T-Kun.; Kuo, D.; Nur-E-Kamal, A.; Liu, L.F., 2003:
Inactivation of Cdc13p triggers MEC1-dependent apoptotic signals in yeast

Kim, J.Min.; Nakao, K.; Nakamura, K.; Saito, I.; Katsuki, M.; Arai, K-ichi.; Masai, H., 2002:
Inactivation of Cdc7 kinase in mouse ES cells results in S-phase arrest and p53-dependent cell death

Chang, H.C.; Holland, R.D.; Bumpus, J.A.; Churchwell, M.I.; Doerge, D.R., 1999:
Inactivation of Coprinus cinereus peroxidase by 4-chloroaniline during turnover: Comparison with horseradish peroxidase and bovine lactoperoxidase

Finch, G.R.; Li, H., 1999:
Inactivation of Cryptosporidium at 1degreeC using ozone or chlorine dioxide